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ABSTRACT
CHARACTERIZATION OF MURINE CYTOMEGALOVIRUS m l42 AND ml43
ESSENTIAL GENE PRODUCTS
Bridget Dalton
Eastern Virginia Medical School and Old Dominion University, 2001 
Director: Dr. Ann Campbell
Cytomegalovirus (CMV) is a species-specific virus belonging to the 
Herpesviridae family. This DNA virus causes severe disease or even death in 
newborns and immunosuppressed patients. Murine CMV (MCMV) provides an 
opportunity to study the role of various viral products in replication and pathology in 
the natural host. Successful replication of CMV in the host depends upon the 
expression o f a cascade of viral genes: immediate early (IE), early (E), and late (L). To 
date only three MCMV IE proteins have been characterized (IE1, IE2 and IE3). Our 
laboratory recently identified a novel IE gene region within the Hind III I region of 
MCMV. These genes, ml42 and ml43, are members of the US22 gene family of 
HCMV, some of which are transcriptional transactivators. The m l42 and ml43 genes 
are also essential for viral replication in fibroblasts.
The purpose of this dissertation was to characterize the m l42 and ml43 
transcripts and proteins, as well as determine if the gene products function as 
transcriptional transactivators like some of the other US22 gene family members. 
Although the m l42 and ml43 transcripts were present during IE times, levels of these 
two transcripts increased during early times of viral infection and remained abundant 
during late times. The genes, ml42 and ml43, encode a 1.8 and 3.8 kb transcript, 
respectively. The m l42 and ml43 proteins (designated pm l42 and pml43, 
respectively) encoded by these transcripts were present by 3 hours post infection and
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remained abundant at 12 and 24 hours post infection. Interestingly, pm 142 and pm 143 
could not be designated as immediate early proteins, because they were not expressed 
in the presence o f drugs that block viral growth at this specific stage within the viral 
replication cycle. Therefore, the m l42 and ml43 immediate early genes do not 
express detectable levels of protein until early times post infection. The pm 142 protein 
is 43 kD protein, and the pml43 protein is 53 kD. The pm l42 and pm 143 proteins 
localized to both the nucleus and the cytoplasm at 3, 4 and 24 hours post infection.
In transactivation studies, we tested the ability o f pm 142 and pm 143 to activate 
the MCMV major immediate early promoter (M122-123) and the early el promoter 
(M l 12-113). In combination, MCMV pml42 and pml43 transactivated the MCMV 
major immediate early promoter and enhancer (MIEPE) in a dose dependent manner 
to at least 3 fold above basal levels. However, individually pm l42 or pml43 failed to 
transactivate the MIEPE. Together, pml42 and pml43 also exhibited noncooperative 
effects with IE1 and IE3 in the activation o f the MCMV MIEPE. In combination, 
pm l42 and pml43 failed to activate the early e l promoter, but pm l42 and pml43 
cooperated with IE 1 and IE3 to activate this promoter. Activation o f the e 1 promoter 
by IE1 and IE3 increased from 30 fold above basal levels in the absence of pm l42 and 
pm l43, to as high as 100 fold above basal levels in the presence o f pm l42 and pml43. 
This was the first time it has been shown that other MCMV viral proteins assist in 
IE1/IE3 mediated transactivation o f the e l promoter or any other promoter, and these 
findings have important implications in MCMV replication.
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The cytomegaloviruses are members o f the herpesvirus family. They share many 
characteristics with the other herpesviruses such as virion and genome structure and the 
ability to establish latent and persistent infection (reviewed in Mocarski, 1996). 
Cytomegaloviruses infect a wide variety o f  host species including rodents, domestic 
animals, and primates (Plummer, 1973). The cytomegaloviruses have several 
distinguishing characteristics. They are highly species specific, display a tropism for the 
salivary gland, have a relatively long replication cycle, and produce cell enlargement with 
intranuclear inclusions (Roizman et al., 1981).
Cytomegalovirus Associated Disease
In North America, the prevalence o f human cytomegalovirus (HCMV) infection 
is about 50% of the population in rural areas (reviewed in Mocarski, 1996). In major 
cities, the prevalence o f cytomegalovirus infection is up to 90% (Mocarski, 1996). In 
immunocompetent individuals, HCMV infection is usually mild or asymptomatic. 
However, the virus persists in the host for life in a latent s^ate, with episodes of 
spontaneous reactivation. The vims can cause severe disease, and even death in those 
individuals with suppressed immune systems. Therefore individuals that are at high risk 
for HCMV disease include the very young, such as the developing fetus or newborn, as 
well as patients undergoing immunosuppressive therapy for either cancer or organ
The model journal for this dissertation is Virology.
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transplantation, or those with immunodeficiency diseases such as AIDS (Mocarski, 
1996).
Approximately 0.5-1% o f all newborns are bom infected with HCMV. However, 
only one out o f ten of these infants demonstrate symptoms at birth. The clinical 
manifestations of congenital HCMV include brain damage, mental retardation, ocular 
damage, hepatic disease and pneumonia. Neurologic damage is a symptom of severe 
disseminated disease (Fjaer et al., 1997; Ahlfors et ah, 1999; Dahle et al., 2000; Coats et 
al., 2000).
Cytomegalovirus is the most important infectious agent affecting organ and bone 
marrow transplant recipients. At least two-thirds of organ transplant and bone marrow 
recipients exhibit evidence of HCMV infection within 1-4 months after transplantation 
(Rubin, 1990; Zaia, 1993; Costa et al., 1999). More serious disease occurs when 
seronegative recipients receive organs from a seropositive donor, since a primary HCMV 
infection ensues under conditions in which the transplant recipient may be 
immunosuppressed. HCMV is also associated with decreased graft survival. It is 
proposed that rejection of the graft is due to a viral-induced increase in the expression of 
MHC antigens within the graft, predisposing the graft to rejection. Alternatively 
molecular mimicry could explain host mediated graft rejection o f the infected organ. In 
this case, HCMV proteins with homology to MHC class 1 molecules within the organ 
induce an immune response against the transplanted organ (Mocarski, 1996; Borchers et 
al., 1999). Transplant recipients with HCMV develop a wide variety of clinical diseases. 
These include prolonged fevers, leukopenia, thrombocytopenia, atypical lymphocytosis
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3and elevated hepatic transaminases. Severe HCMV infections are associated with 
gastrointestinal problems, hepatitis and pneumonia (Ho, 1991).
HCMV is also one o f the most important opportunistic infections encountered in 
AIDS patients. About 90% of AIDS patients develop HCMV infection, and up to 40% 
may develop vision and/or life threatening HCMV induced disease (Gallant et al., 1992). 
The most common manifestations of disease include encephalitis, retinitis, colitis and 
CMV pneumonitis (Roullet, 1999; Chakraborty, 1999; Soloman and Perlman, 1999) .
The link between HCMV and AIDS could be due to molecular interactions between HIV 
and HCMV. The HIV long terminal repeat is transcriptionally activated by the HCMV 
major immediate early (IE) proteins, and HCMV replication is enhanced by the presence 
of active HIV infection (Rando et al., 1990; Walker et al., 1992; McCarthy et al., 1998; 
Yurochko et al., 1999). However to date, the role of HCMV in AIDS is poorly 
understood.
Cytomegalovirus Pathogenesis
HCMV is usually spread by direct or indirect person to person contact (reviewed 
in Mocarski, 1996). Sources of the virus include the saliva, urine, cervical and vaginal 
secretions, semen, breast milk, tears, feces and blood. In individuals with severe 
disseminated HCMV, virtually all organ systems may be affected. However, the salivary 
gland, the genitourinary tract, the gastrointestinal tract, the respiratory tract, the central 
nervous system, and the liver are sites commonly involved in HCMV infections of 
immunosuppressed individuals. In individuals with a normal immune system, no clinical 
evidence of infection occurs. However, the virus remains associated with the individual
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4for life, either as an asymptomatic productive infection or in a latent state (Mocarski, 
1996).
Cellular immune responses are important in curtailing the virus infection and 
maintaining the virus-host equilibrium in persistent HCMV infection (Alp et al., 1991). 
Natural killer cells are activated early after viral infection and are a part of the non­
specific immune response. During this time, interferon alpha/beta are produced by 
macrophages, and they represent another non-specific antiviral defense mechanism. Cell 
mediated immunity involving CD4+ and CD8+ T lymphocytes are responsible for 
clearing the virus from target organs. The HCMV immediate early 1 (IE1) protein is a 
target for CD8+ T cells in humans (Alp et al., 1991), as is the equivalent IE1 protein in 
mice (Reddehase et al., 1987). Several late HCMV proteins are also the target of specific 
cytotoxic T cell responses. These proteins include pp65, gB, ppl50 and pp28 
(McLaughlin-Taylor et al., 1994; Hopkins et al., 1996; Li et al., 1997; Gyulai et al., 
2000). HCMV IE1 also contains several immunodominant polypeptides, which elicit an 
antibody response against HCMV (Landini and La Placa, 1991). The CD4+ T cells are 
important helper cells for antibody and CD8+ responses (Alp et al., 1991). Antibodies 
may control systemic spread of recurrent infections following reactivation, however they 
do not participate in clearing virus from target organs (Landini and La Placa, 1991).
HCMV infects several different cell types. These include epithelial, endothelial, 
mesothelial, fibroblast, and glial cells (Sinzger et al., 1993). Leukocytes circulating in 
the peripheral blood are also susceptible to CMV infection (Sinzger et al., 1996) and 
these cells play a central role in viral pathogenesis. More specifically, the monocyte 
precursor cell or CD34+ bone marrow progenitor cell has been shown to harbor HCMV
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5DNA in the form of a circular plasmid (Bolovan-Fritts et al, 1999), under conditions in 
which transcription from the viral genome is limited. However when these cells are 
allowed to differentiate in culture, infectious virus can be recovered. Therefore in vivo, 
the CD34+ bone marrow progenitor cell serves as a reservoir o f latent virus and also as a 
vehicle for disseminating the virus to target organs (Maciejewski et al, 1992; Mendelson 
et al., 1996; Maciejewski and St Jeor, 1999). The CD34+ cells differentiate into CD33+ 
cells. Latent infection, the expression o f latency associated transcripts, and reactivation 
o f virus upon cellular differentiation has also been demonstrated in cells coexpressing 
CD33 and CD 15 or CD33 and CD 14 along with dendritic cell markers (Hahn et al,
1998).
During latency, HCMV viral gene expression is restricted such that only 
immediate early transcripts are detected. The immediate early transcripts expressed 
during latency originate from a single locus, the major immediate early gene locus. Two 
genes are expressed from this locus during latency (iel and ie2); however, these 
transcripts differ significantly from those present during a productive infection. Latent 
transcripts called sense transcripts are encoded in the same direction as productive phase 
transcripts but use novel start sites in the HCMV iel/ie2 promoter region. Other latent 
transcripts called antisense transcripts are unspliced and are complementary to exons 
within iel. Antibody to the proteins encoded by these transcripts are detectable in the 
serum o f seropositive individuals implying that protein products are synthesized from 
these transcripts during latent or productive infection (Kondo et al., 1994; Kondo and 
Mocarski, 1996; Landini et al., 2000).
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6Factors that cause the latently infected monocyte precursor cell to differentiate 
into a fully permissive macrophage contribute to HCMV reactivation. When myeloid 
progenitor cells are experimentally infected, HCMV can be reactivated when these cells 
are cultured in the presence of interferon gamma, tumor necrosis factor alpha (TNFa), 
interleukin-4 (IL-4) or granulocyte-macrophage-colony-stimulating factor (GM-CSF) 
(Hahn et al., 1998). These cells can also reactivate when cultured in the presence of 
fibroblasts or fibroblast conditioned medium. Naturally infected macrophage progenitor 
cells can reactivate latent HCMV when allogeneically stimulated. The cytokine 
interferon-gamma, but not IL-4, TNF or GM-CSF, is essential for reactivation in these 
cells (Soderberg-Naucler et al., 1998). Therefore, there are differences between 
experimentally and naturally infected cells.
The murine model has been used to address the role that monocytes and 
macrophages play in the pathogenesis of cytomegalovirus infection. Since CMV is 
species specific, MCMV infection offers the opportunity to study CMV disease, 
protection against it, and conditions for establishing persistent and latent infection in the 
natural host. In the mouse model, the macrophage progenitor cell not only is one of the 
first cell types to support MCMV replication during infection, but macrophages also 
disseminate the vims to the spleen, lung, and liver, and harbor latent MCMV DNA 
(Collins et al., 1993; Stoddart, 1994; Pollock and Virgin, 1995; Koffron et al., 1998).
On the other hand, the infected macrophage triggers the early innate immune response 
by producing monokines like interferon alpha/beta, TNF alpha, and IL-12. Interferon 
alpha leads to the activation of NK cells, which produce interferon gamma. Interferon
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7gamma activates macrophages which makes them less permissive and limits viral gene 
expression, and along with IL-12 activates CTLs (Hanson et al., 1999).
As stated previously, monocyte progenitor cells are a source of latent CMV and 
also serve as a source o f CMV dissemination and reactivation (Zhuravskaya et al., 1997). 
During latency, monocytes harbor viral DNA; however, the presence of infectious virus 
can not be detected. In mice, macrophages that are latently infected with MCMV contain 
as many as 10 copies o f the MCMV genome per cell. When the latently infected 
monocyte is cocultured with murine embryonic fibroblast cells, infectious virus is 
reactivated (Pollock et al., 1997). Latency has been observed in the heart, kidney, liver, 
lung, spleen, brain, and salivary glands of mice (Collins et al., 1993, Reddehase et al., 
1994).
During latency in the lung, transcription from the MCMV major immediate early 
promoter occurs (Kurz et al., 1999; Kurz and Reddehase, 1999). Under these conditions 
transcription is restricted to iel, while the ie3 transcript equivalent to ie2 of HCMV is 
absent. The transcription o f iel in the lung tissue during latency is focal and randomly 
distributed, although the viral genome is evenly distributed throughout the entire organ. 
Foci that express iel may be progressing through several sequentially ordered control 
points that when passed, will lead to recurrence (Kurz et al., 1999; Kurz and Reddehase, 
1999). The switch from iel to ie3 precursor mRNA transcriptional processing may 
trigger this transition. During recurrence, iel transcription in the lung is generalized, and 
the ie3 transcript is present (Kurz et al., 1999; Kurz and Reddehase, 1999).
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8The Viral Genome
Human CMV has a very large genome, o f over 230 kilobase pairs, encoding over 
230 genes (Chee et al., 1990). These genes are numbered sequentially within the viral 
genome. The genome is arranged in a very complex manner, containing internal 
reiterated sequences that enable the virus double-stranded DNA to arrange in four 
genomic isomers. For example, HCMV has sequences from both termini that are 
repeated in an inverted orientation and juxtaposed internally dividing the genome into a 
unique long region and a unique short region (UL and US), each flanked by internal 
repeats. The unique long region of HCMV is flanked by terminal repeat sequences 
(TRL) and internal repeat sequences (IRL). Likewise, the unique short region o f the 
virus is flanked by terminal repeat sequences (TRS) and internal repeat sequences (IRS) 
(Jahn and Sinzger, 1996). HCMV genes are named according to their location within the 
repeat sequences or unique regions o f the viral genome as well as their number within the 
HCMV genome (ex. UL112).
In HCMV the unique components can invert relative to each other during 
replication giving rise to the four genomic isomers. Virally infected cells can contain any 
one o f the four isomers and each isomer is present at equimolar concentrations (Oram et 
al., 1982). The MCMV genome however, consists primarily of unique sequences with 
few repeat sequences. Therefore, no isomers are present in the murine strain. Although 
the HCMV and MCMV genomes have been completely sequenced, analysis o f individual 
gene function is incomplete. However, HCMV and MCMV genes are characterized as 
either essential or non-essential for viral growth in cultured cells. Essential genes are 
those required for virion structure and vims replication in tissue culture, whereas non­
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9essential genes are those not required for virus growth in cell culture but may be involved 
in virus/host interactions in vivo (Mocarski et al., 1990).
The Virion Structure
CMV has an icosahedral virion structure containing the double stranded DNA 
genome, and is surrounded by a tegument. These components are packaged in a lipid 
bilayer envelope containing virally encoded glycoproteins (Wright et al., 1964).
The CMV capsid contains seven proteins. These proteins include the 
major capsid protein (UL86), the minor capsid protein (UL85), the minor capsid binding 
protein (UL46), the smallest capsid protein (UL48.5), and three distinct 
assemblin/assembly proteins (UL80.5, UL80, and UL80a). These proteins make up the 
structure of the capsid or are involved in capsid assembly (Mocarski, 2000).
An array o f fibrous, granular proteins called tegument proteins are interfaced 
between the capsid and the envelope. There are 25 tegument proteins and most of these 
proteins are phosphorylated and denoted by the prefix "pp". The function o f most 
tegument proteins is unknown. However, several have been shown to function as 
transcriptional transactivators (Mocarski, 2000). For example, HCMV pp71 (UL82) is a 
tegument protein, which activates HCMV IE gene expression and increases the 
infectivity of HCMV DNA (Lui and Stinski, 1992; Baldick et al., 1997; Chau et al.,
1999). Recently, several HCMV transcripts called virion RNAs were found to be 
packaged within the virion (Bresnahan and Shenk, 2000). The function of the putative 
proteins encoded by these transcripts is unknown (Bresnahan and Shenk, 2000).
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The viral envelope is composed o f a lipid bilayer membrane containing eight 
virally encoded glycoproteins. The viral envelope contains two prominent glycoprotein 
complexes. One is composed o f  dimers o f gB (UL55), and the other is composed of gH, 
gL and gO (UL75, UL115, and UL74) (Mocarski, 2000). Several o f  these glycoproteins 
are highly conserved among the herpesviruses (gB, gH, gL, and gM). These proteins are 
involved in virion attachment, penetration, transmission from cell to cell, and fusion of 
infected cells (Britt and Mach, 1996). These proteins, in particular glycoprotein gB, are 
also targets o f  the host humoral immune response (Navarro et al., 1997). The envelope of 
CMV renders this vims sensitive to low pH, lipid solvents and heat; accordingly, virions 
have a half life o f approximately 60 minutes at 37 degrees Celsius (Vonka and Benyesh- 
Melnick, 1966).
Cytomegalovirus Attachment/Penetration
The initial event in the viral replication cycle is viral attachment. During viral 
attachment, the viral envelope protein gB binds to cell surface heparin sulfate (Compton 
et al., 1993; Navarro et al., 1993; Boyle and Compton, 1998). The initial interaction 
with heparin sulfate is followed by a more specific interaction between the vims and a 
cellular receptor. The cellular receptor that mediates this event is unknown. It was 
proposed that a 30-36 kDa gB-binding cell surface protein is involved in attachment. 
However when this protein, which has been identified as annexin II, was blocked with 
annexin II specific antibodies, viral entry was not hampered. These experiments suggest 
that annexin II is not the true molecule involved in CMV attachment and penetration 
(Pietropaolo and Compton, 1999).
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After the virus particle has attached to the cell surface, penetration occurs within 5 
minutes (Bodaghi et al., 1999). HCMV penetrates the host cell in a pH independent 
manner mediated by fusion between the viral envelope and the host cell plasma 
membrane. This event likely involves the complex o f envelope glycoproteins gH, gL and 
gO (Compton et al., 1992). Following viral entry, the viral nucleocapsids enter the 
nuclear pores and deliver the viral DNA to the nucleus for expression (Bodaghi et al.,
1999).
Cytomegalovirus Replication
Cytomegalovirus genes are expressed in three sequential phases: immediate early, 
early, and late. Immediate early gene expression does not require de novo protein 
synthesis. The immediate early gene products activate the expression o f the early genes 
and serve to autoregulate their own expression. The early genes encode proteins involved 
in DNA replication; for example the DNA polymerase, the DNA polymerase accessory 
protein, and the helicase/primase complex. Other early genes are not required for viral 
DNA replication, but are involved in viral pathogenesis, tissue tropism and immune 
evasion. Late genes encode structural proteins involved in packaging the viral genome, 
such as the tegument proteins and the envelope glycoproteins (Mocarski, 1996).
Drugs have been used to define the three classes of CMV genes expressed in an 
infected cell. The drugs anisomycin and cycloheximide prevent protein synthesis, 
thereby allowing expression o f only the immediate early genes from a CMV infected cell. 
Gancyclovir and phosphonoacetic acid prevent viral DNA replication by causing 
premature nucleic acid chain termination and inhibition o f the activity o f the viral DNA
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polymerase. Therefore the replication cycle is blocked at the expression of the early 
genes. Late genes are those that are expressed following viral DNA replication. These 
genes are expressed when the viral genome is allowed to replicate completely in the 
absence o f drug inhibitors.
Recently DNA microarray technology has been used to study the three classes of 
viral genes expressed from CMV infected cells. This system allows all HCMV genes to 
be studied simultaneously. Briefly, a DNA microarray containing sequences from each 
individual viral open reading frame was printed on glass slides. These viral 
oligonucleotides were then analyzed in a single hybridization step using flourescently 
labeled cDNA from virally infected cells as a probe. The viral cDNA was obtained from 
cells that had been treated with the drug inhibitors mentioned previously. The results 
displayed a temporal map of both known and previously unknown immediate early (IE), 
early (E), and late (L) genes of the entire HCMV genome. Since this system allows the 
study of over 200 genes in a single experiment, it is particularly important when studying 
large viral genomes like those in HCMV (Chambers et al., 1999).
In MCMV, immediate early genes are expressed 0-3 hours post infection, early 
genes are expressd 3-12 hours post infection and late genes are expressed 12-24 hours 
post infection (Keil et al., 1984; Messerle et al., 1991; Messerle et al., 1992). HCMV 
replication occurs much slower than MCMV replication. The immediate early genes are 
expressed 0-24 hours, early genes are expressed 24-48 hours and late genes are expressed 
48-72 hours post infection.
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HCMV Major Immediate Early Genes
There are five regions within the HCMV genome that are transcribed at 
immediate early times. These include UL36-38, UL122-123, TRS1-IRS1, UL69 and 
US3. The majority of the IE transcripts arise from the UL122-123 locus and are referred 
to as major immediate early proteins (Fig. 1). The major immediate early genes are 
designated by lower case letters (ex. iel), while the major immediate early proteins are 
designated by upper case letters (ex. IE1). Two immediate early proteins (IE55 and 
IE 18) are expressed at low levels by differential splicing from this region and likely 
influence cell type specificity. Two predominant proteins also originate from this gene 
region by differential splicing, the 72 kDa EE1 protein and the 86kDa IE2 protein (Stinski 
et al., 1983; Stenberg et al., 1984; Stenberg et al., 1985; Stenberg et al., 1989; Kerry et 
al., 1995). The IE1 and IE2 gene products have been implicated in the positive regulation 
of viral gene expression (Stenberg et al., 1990). IE I activates expression of the IE1/IE2 
enhancer (Stenberg et al., 1990). IE1/IE2 is also required for DNA replication by 
functioning to activate early proteins required for DNA synthesis (Kerry et al., 1994, 
Kerry et al., 1996). In addition to its ability to autostimulate its own synthesis, IE1 
cooperates with IE2 in the activation of subsequent kinetic classes of gene expression 
(Stenberg et al., 1996; Colberg-Poley et al., 1992; Fortunato and Spector, 1999). For 
example, although the UL112-113 promoter is efficiently transactivated by IE2 alone, 
this activation is augmented by IE1 (Colberg-Poley et al., 1992). IE2 is involved in the 
shut off of IE1/IE2 gene expression (Stenberg et al., 1990), thought to occur by direct 
DNA binding to the cis repression sequence (crs). The crs spans the IE 1/2 promoter CAP 
site (Lang and Stamminger, 1993), and IE2 binding interferes with assembly of the
















FIG. 1. Structural organization o f the human and murine CMV major 
immediate early gene loci. The HCMV IE early gene region (UL122-123) 
is located between HCMV sequences 169367-172783. There are four IE 
mRNAs originating from this region by differential splicing. The MCMV IE 
gene region (M l 12-113) is located between MCMV sequences 177009-181933. 
There are three IE mRNAs originating from this region by differential splicing. 
The arrows depict transcripts, with the exon number underneath. The black 
boxes represent the enhancer region (Stenberg et al., 1989; Kerry et al., 1995; 
Keil et al., 1987). The bold numbers denote the name of the IE protein products.
preinitiation complex (Wu et al., 1993). IE2 is also a promiscuous transactivator o f 
cellular genes, especially when used in conjunction with IE I (Stenberg et al., 1990). IE2 
upregulates the hsp70, c-fos and c-myc promoters but transactivation by IE1 and IE2 
together is synergistic (Hagemeier et al., 1992).
The expression of the HCMV immediate early proteins is controlled by a very 
strong and complex enhancer (iel/ie2 enhancer) (Fig. 2). This enhancer is active in a cell 
type and tissue specific manner. In transgenic mice containing the LacZ gene under the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15
Modulator NF1 Region Enhancer Pro
4 ----------------►-<-------------- ►<------------------------------------------------- ►
-1000 -500 <
i I I I_______ I * »_______i »  i i
TFIID t
NF-kB t  t  t  t
API f t
CRE/ATF t  t  t  t
spi + + t  m
C/EBP t  f t
NFL t  f t
SRE +
FIG  2. The upstream regulatory domains within the HCMV MIEP. A very 
strong and complex enhancer controls the expression of the HCMV immediate 
early genes, and this enhancer is active in a cell type and tissue specific manner. 
The activity o f this promoter is driven by a wide variety of cellular transcription 
factor binding sites present within the enhancer region. The promoter (pro), 
enhancer, NF1 and modulator regions are denoted by bidirectional arrows. The 
transcription factor binding sites are denoted by arrowheads and the region on 
the promoter to which they bind has been mapped. (Mocarski, 1996).
control of the HCMV major immediate early promoter, expression o f LacZ was found in 
19 out o f 29 tissues. These tissues include the brain, eye, spinal cord, esophagus, 
stomach, pancreas, kidney, bladder, testes, ovary, spleen, salivary gland, thymus, bone 
marrow, skin, cartilage and muscle. Distinct cell types within these tissues expressed 
LacZ. These cell types include retinal cells o f the eye, ductile cells of the salivary gland, 
exocrine cells o f the pancreas, mucosal cells o f the stomach and intestine, neuronal cells 
of the brain, muscle fibers, thecal cells of the corpus luteum, and Leydig and sperm cells 
of the testes (Baskar et al., 1996). The level o f differentiation of the infected cell also
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influences the activity of this enhancer (Stamminger et al., 1990; Stein et al., 1993; Chan 
etal., 1996; Baskaretal., 1996; Shering et al., 1997).
The strength of the HCMV ie l/ie2 enhancer can be attributed to a wide variety of 
cellular transcription factor binding sites present within the DNA sequence. These 
transcription factors include CREB/ATF, AP-1, NFkB, SP1, serum response factor and 
NF1 (Mocarski, 2000). These factors bind to repeat elements, which are referred to by 
their size (16-, 18-, 19- and 21- bp repeats). The transcription factor YY1 binds to a 
region in the MIEP called the modulator. YY1 seems to modulate expression from this 
enhancer by either acting as a repressor or as an activator of transcription (Lui et al.,
1994). The modulator however, is not necessary for the transcription of the HCMV IE 
genes (Meier and Stinski, 1997).
In order to determine the importance o f this enhancer, HCMV mutant viruses 
have been made in which the HCMV major immediate early enhancer has been deleted. 
Results indicate that the deletion o f the enhancer impairs virus growth in human 
fibroblasts severely at a low multiplicity o f infection (MOI). However, at a high MOI, 
viral growth in human fibroblasts is not inhibited when the MIEP is deleted. Therefore 
the MIEP is important in augmenting viral IE gene expression under conditions in which 
few viral DNA copies are present (Meier and Pruessner, 2000).
A HCMV IE1 mutant virus has also been made. This virus is deleted of exon 4 of 
IE I. In vitro, this virus is unable to replicate in human fibroblast cells at a low MOI. At 
a low MOI, the IE1 mutant virus also failed to form viral DNA replication compartments 
and to express the DNA polymerase accessory protein (ppUL44) which is required for 
viral DNA replication (Greaves and Mocarski, 1998). However, at an MOI of at least
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three plaque forming units, the virus is able to replicate at levels similar to wild-type 
virus (Mocarski et al., 1996). At a high MOI, the IE1 mutant virus was likely able to 
replicate due to the presence o f virion proteins which have the ability to compensate for 
the lack o f LEI by transactivating the MIEP.
HCMV Ancillary IE Genes
All of the HCMV ancillary IE proteins also regulate gene expression and interact 
cooperatively. UL36-38 and US3 immediate early gene products regulate gene 
expression of the hsp70 promoter, and this expression was synergistically increased when 
both US3 and UL36-38 were transfected together (Colberg-Poley et al., 1992). HCMV 
US3 is also involved in immune evasion by blocking the transport o f MHC class 1 heavy 
chains from the Golgi complex through the endoplasmic reticulum (Jones et al., 1996). 
UL37 is a type 1 integral membrane N-glycoprotein, and is proposed to regulate nuclear 
gene expression by cell signaling (Zhang et al., 1996). The IE proteins UL36-UL38,
IRS 1/TRS1, and U L122-123 are required for HCMV ori Lyt DNA replication. These 
proteins cooperatively regulate the expression of the early proteins involved in DNA 
replication (Pari and Anders, 1993; Pari et al., 1993; Iskenderian et al., 1996; Kerry et al., 
1996).
HCMV Early Regulatory Genes
Early CMV genes are expressed prior to viral DNA replication and encode 
enzymes required for viral DNA replication. The early proteins involved in DNA 
replication have been identified due to their homology to herpes simplex virus type 1
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(HSV-1) genes which are essential for HSV-L replication (McGeoch et al., 1988; Wu et 
ah, 1988). The HCMV early genes involved in viral DNA replication include the DNA 
polymerase UL54, the polymerase-accessory protein UL44, the single-stranded DNA 
binding protein UL57, and the proposed subunits o f the helicase-primase complex, UL70, 
UL105 and UL101-102 (Kouzarides et al., 1987; Heilbronn et al., 1987; Anders and 
Gibson, 1988; Martignetti, 1991; Ertl and Powell, 1992). The viral DNA polymerase 
(UL54) shares extensive amino acid homology with the DNA polymerase of HSV-1. The 
HCMV DNA polymerase is found associated with an additional polypeptide in virally 
infected cells, the DNA polymerase accessory protein (UL44). This protein is the CMV 
homolog of the DNA polymerase accessory protein o f HSV-1 (Ertl and Powell, 1992). 
The DNA polymerase accessory protein functions to stimulate DNA polymerase activity 
by increasing the processivity o f the DNA polymerase enzyme (Ertl and Powell, 1992). 
The single stranded DNA binding protein (UL57) binds to single stranded DNA and 
anchors the polymerase to the replication complex (Anders et al., 1986). The helicase 
complex (UL70, UL105 and U L101-102) is involved in priming lagging strand synthesis 
and unwinding DNA at the replication fork (Crute et al., 1989; Martignetti and Barrell, 
1991). The sequence o f the CMV helicase complex is also similar to the helicase 
complex of HSV-1. The two remaining proteins, UL84 and UL112-UL113, encode 
nuclear localized proteins. UL112-UL113 helps to regulate expression of the replication 
fork proteins (Iskenderian, 1996; Kerry 1996), while UL84 is required for the formation 
of intranuclear replication compartments (Sarisky and Hayward, 1996; Yamamoto et al.,
1998).
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In order for the expression o f the viral DNA replication genes and subsequent 
viral DNA replication to occur, the presence of the immediate early proteins is necessary. 
The immediate early proteins which are required to complement HCMV DNA replication 
in transient transfection assays include UL36-38, IRS1/TRSI, and IE1 and EE2 (UL122- 
123). These proteins are involved in regulating the expression o f the early genes required 
for DNA replication, and they act synergistically in activating the expression of these 
genes (Iskenderian et al., 1996, Kerry et al., 1996). Not only are the immediate early 
genes important in activating the early gene promoters, but cellular factors play an 
important role as well. The cellular proteins ATF-1 and SP-1 assist the immediate early 
proteins in regulating the DNA polymerase promoter (Kerry et al, 1996; Kerry et al., 
1997; Luu and Flores, 1997). The cellular factors CREB and ATF are required for full 
activation o f the US 11 and UL112-113 early promoters (Rodems et al., 1998; Chau et al.,
1999). The presence of these cellular factors, which work in conjunction with the 
immediate early proteins in activating viral early promoters, likely influence cell-specific 
transactivation o f viral genes.
HCMV Late Genes
Following early gene expression, viral DNA is replicated in a rolling circle 
mechanism that yeilds head to tail concatemers of unit length DNA. Following DNA 
replication, the late genes are expressed. These encode the structural proteins of the 
virion (see Virion Structure). Since very few late genes have been studied, very little is 
known about their regulation. The late gene pp65, which encodes the lower-matrix 
phosphoprotein, has been studied in transient transfection assays. In these assays, the
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pp65 promoter is activated by the IE1 and IE2 proteins, and a 8-base pair sequence 
appears to be important in the regulation o f this promoter (Depto and Stenberg, 1989). 
The HCMV UL94 gene product, which encodes a virion protein, has been studied as 
well. These studies indicate that a positive and negative regulatory region is present 
within the UL94 promoter, and the cellular protein p53 plays a central role in regulating 
this promoter (Wing et al., 1998). Functional analyses of the pp28 promoter indicate that 
a 10 base pair sequence is important for promoter activation. This suggests that viral or 
cellular factors may act through these specific sequences to activate late gene expression 
(Depto and Stenberg, 1992).
Viral Assembly And Egress
Following late gene expression, the viral DNA is processed into genome length 
monomers and packaged in the viral capsids in the nucleus. Viral glycoproteins and 
tegument proteins accumulate and form patches in the nuclear membrane. The capsids 
then attach to a patch of modified inner lamellae of the nuclear membrane and become 
enveloped (Radsak et al., 1990). Although the nuclear membrane is the initial site of 
envelopment, this coat is removed in the cytoplasm (de-envelopment). The virion is then 
transported in vesicles through the Golgi to the cell surface (Eggers et al., 1992; Whiteley 
et al., 1999). Re-envelopment occurs as the virion buds from the cellular membrane, 
which is also modified by viral glycoproteins (Stinski et al., 1979). Therefore, egress 
from the cell may follow the exocytic pathway although this has not been definitively 
established and is still under investigation (Mocarski, 1996).
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MCMV As a Model For HCMV Disease
Due to the strict species specificity o f the cytomegaloviruses, murine 
cytomegalovirus (MCMV) has been used as a model for human cytomegalovirus disease. 
Human and murine cytomegaloviruses share several characteristics. They both contain a 
large DNA genome o f approximately 230 kilobases in length. HCMV and MCMV also 
have significant similarity in gene families, the presence of short direct and internal 
repeat sequences, and similar G and C content (particularly within the central part of the 
genome). Furthermore, the central part of the MCMV genome is colinear and generally 
homologous to the HCMV genome. The MCMV genes with homology to HCMV are 
indicated by the uppercase prefix M (ex. M l 12) while the MCMV genes with minimal 
sequence similarity to HCMV are indicated by the lowercase prefix m (ex. m40).
The functions of several MCMV gene products can be predicted based on 
sequence homology with HCMV genes or have been proven based on functional assays 
(Rawlinson et al., 1996). Finally, both viruses are biologically similar in terms of tissue 
tropism, latency and reactivation (Mocarski et al., 1990; Campbell, 1999).
MCMV Immediate Early Genes
To date only three MCMV immediate early genes have been characterized 
(M122, m l23 and ml28). These are located between map units 0.769 - 0.817, a region 
roughly colinear with the HCMV immediate early region (Kosinowski et al., 1986; Keil 
et al., 1987a; Keil et al., 1987b; Messerle et al., 1991; Messerle et al., 1992; Cardin et al.,
1995). MCMV iel (ml23) and MCMV ie3 (M122) genes are expressed from the same 
promoter from right to left and have a similar splicing pattern as the HCMV IE proteins
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(Fig. 1). MCMV IE1 is composed o f exons 1-4, while MCMV IE3 is composed of exons 
1-3, and 5 (Keil et al., 1987a; Keil et al., 1987b; Messerle et al., 1992). The MCMV ie2 
gene (m l 28) is transcribed from a separate promoter in the opposite direction of the 
MCMV iel/ie3 and is composed o f three exons (Keil et al., 1987a; Messerle et al., 1991; 
Cardin et al., 1995). However, all three of these ie genes share the same strong enhancer 
(Fig. 1).
The expression of the MCMV immediate early genes is also driven by a strong 
and complex enhancer (Dorsh-Hasler et al., 1985). This enhancer region contains three 
long repeats of 181, 180, and 130 base pairs, and included within these repeats are five 51 
base pair repeats containing NF-kB binding sites (Sandford and Bums, 1996). These NF- 
kB binding sites mediate transactivation of the MCMV enhancer by the immediate early 
protein IE I (Cherrington and Mocarski, 1989). There are also binding sites for API and 
CRE, but no binding sites for NF-1, SP1, or YY1 (Sandford and Bums, 1996). Since AJP- 
1 and NFkB binding sites are present, expression from the enhancer is driven by serum 
and growth factors. This stimulation o f the MCMV IE enhancer occurs through a 
pathway in which p21 ras is involved (Angeretti et al., 1994). Therefore the enhancer is 
active under conditions in which the cell is metabolically active.
In order to determine the importance of the MCMV major immediate early 
enhancer, MCMV mutant viruses have been made in which the MCMV immediate early 
enhancer has been deleted. For these MCMV mutants, viral growth is impaired in mouse 
fibroblast cells (NIH 3T3 cells). Since viral growth is not inhibited completely, the 
enhancer is not essential for viral replication but is required for optimal levels of viral 
infection to occur in permissive cells. When the HCMV enhancer is used to substitute for
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the MCMV enhancer (hybrid MCMV strains), the HCMV enhancer is able to restore 
growth in fibroblasts to kinetics similar to wild type MCMV (Angulo et al., 1998; 
Grzimek et al., 1999). When mice are infected with this virus, liver cells are infected to 
similar levels as wildtype virus. However the mutant virus is attenuated in the spleen, 
lung, and adrenal gland (Grzimek et al., 1999). This suggests that the MCMV enhancer 
is active in a tissue specific manner.
The MCMV IE1 gene product is an 89kDa nuclear phosphoprotein analogous to 
the HCMV IE I gene product. The MCMV IE I gene product transactivates the iel/ie3 
promoter and several other promoters such as the SV40 promoter, the early HSV-1 gD 
promoter, and the NF-kB p!05/p50 promoter (Koszinowski et al., 1986; Gribaudo et al.,
1996). The MCMV IE3 gene product (88kDa) is analogous to HCMV IE2 and represses 
the MCMV iel/ie3 promoter. In transient assays using a construct containing the MCMV 
MIEP cloned upstream o f the chloramphenicol acetyl transferase (CAT) gene, a low level 
of CAT activity was found with IE1 alone, and this activity was reduced by 5 fold with 
IE1 and IE3 (Fig. 3) (Messerle et al., 1992, Cardin et al., 1995).
In addition to having sequence similarity to the carboxyl terminus of the HCMV 
IE2 protein, both MCMV IE3 and HCMV IE2 exhibit functional similarity in activating 
the expression o f early genes. The MCMV IE3 protein is a strong transcriptional 
transactivator of the murine CMV early promoter el (Ml 12-MI 13). In transient assays 
using the e l promoter cloned upstream of CAT, IE3 was able to increase CAT activity by 
150 fold. When the e l promoter-CAT construct was cotransfected with IE1 and IE3, a 
200 fold increase in CAT activity was observed. Therefore, together MCMV IE1 and 
IE3 act synergistically in activating the el promoter (Fig. 3) (Messerle et al., 1992).
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Finally, the MCMV LE2 gene product has no obvious counterpart in HCMV, but 
it too transactivates the MCMV ie 1/3, the ie2 promoter and the HSV-1 ICP8 promoter 
(Cardin et al., 1995). In transient studies of the MIEP using the Escherichia coli lacZ 
gene as a reporter, IE2 was able to activate this promoter 12 fold above basal levels in a 
dose dependent manner (Cardin et al., 1995). IE2 was able to autoregulate the expression 








FIG. 3. Model of MCMV IE protein function. Influence o f IE 1 and IE3 
on the MCMV MIEP and the early e l promoter is depicted. Arrows from the 
proteins indicate the interaction of the proteins and their subsequent influence 
on the promoters. The relative levels o f activation (+) and repression (-) of 
the promoters by IE proteins are indicated. The lack of an influence on promoter 
activation is indicated by 0  (Messerle et al., 1992).
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Like IE1 o f HCMV, MCMV EE1 is not necessary for growth in cell culture.
When a low MOI was used to infect mouse NIH3T3 fibroblast cells with a MCMV iel 
mutant virus, the IE1 mutant grew significantly slower than wild-type virus. However 
when the MOI was increased, replication was restored to levels similar to wild type 
(Messerle et al., 1997). This can be explained by the phenomenon referred to as 
“multiple hits” . When the MOI is high, other factors are able to compensate for the lack 
o f  IE1 in activating the MIEP. Compensating factors could include transactivating 
proteins within the tegument (Mocarski et al., 1996). Although MCMV IE1 is 
dispensible for growth in culture, a MCMV mutant deleted o f the MIEP and part o f exon 
1 of iel/ie3 is replication incompetent in cultured ceils (Angulo et al., 1998).
IE2 also is dispensible for growth in NIH3T3 cells. An IE2 deletion mutant 
displayed similar growth kinetics as wildtype virus in vitro (Cardin et al., 1995; Manning 
and Mocarski, 1998). In vivo, the IE2 mutant virus grows to similar levels as wild type 
virus in the spleen, liver, kidney and adrenal glands. In the absence of IE2, the 
establishment o f and reactivation from latency also occurs to levels similar to wildtype 
virus (Cardin et al., 1995).
MCMV Non-essential Genes
MCMV genes are classified as either non-essential or essential. The essential 
genes are those required for viral attachment/penetration, viral DNA replication in 
fibroblast cells, or viral packaging. Non-essential genes are not required for viral DNA 
replication in fibroblasts, but likely influence tissue tropism and/or viral pathogenesis. 
Several MCMV non-essential genes have been studied to date. The sgg-1 gene (M l33)
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and the G protein-coupled receptor homolog gene (M33) are involved in MCMV growth 
in the salivary gland (Lagenaur et al., 1994; Davis-Poynter et al., 1997). The chemokine 
homolog m l3 1 is also involved in infection o f the salivary gland by eliciting 
proinflammatory signals which may be important for dissemination to or replication of 
MCMV in this organ (Fleming et al., 1999).
Like HCMV, several MCMV non-essential genes interfere with the expression o f 
MHC class 1 molecules on the surface of an infected cell. The ml 52 gene blocks antigen 
presentation by preventing the export o f MHC class 1 molecules from the endoplasmic 
reticulum through the Golgi (Zeigler et al., 1997). The m06 gene allows the MHC class I 
molecules to be transported from the endoplasmic reticulum through the Golgi, however 
the MHC class 1 molecule is not expressed on the surface o f the cell but is redirected to 
the lysosome and rapidly degraded. The mouse gp34 protein (m04), which is also 
nonessential, counteracts the MHC class 1 inhibition by m l52 and m06, and associates 
with the MHC class 1 molecules as they are transported to the cell surface. This may 
allow the infected cell to escape recognition by natural killer cells by increasing MHC 
class 1 levels at the cell surface (Kleijnen et al., 1997). Another MCMV non-essential 
gene encodes the MCMV IgG Fc receptor (M138).
US22 Gene Family
One gene family likely to influence viral pathogenesis is the US22 gene family. 
Members of the US22 gene family have been found in HCMV (Weston and Barrell, 
1986), MCMV (Rawlinson et al., 1996), HHV-6 (Nicholas and Martin, 1994), and HHV- 
7 (Nicholas, 1996). These are all betaherpesviruses that infect myeloid and lymphoid
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
27
cells. The functions o f  many members of the US22 gene family are unknown. However 
certain members o f the family, HCMV TRS 1/IRS land UL36, MCMV ie2, and some 
ORFs within the region o f homology in HHV-6, encode transcriptional transactivators 
(Cardin et al., 1989; Stasiak and Mocarski, 1992; Nicholas and Martin, 1994; Iskenderian 
et al., 1996).
Conserved motifs contained within the US22 gene family. US22 family members 
contain up to four conserved consensus sequences that are referred to as motifs 
(Kouzarides et al., 1988; Nicholas and Martin, 1994). The US22 motifs I and II are 
composed of conserved sequences containing hydrophobic residues. Motif I contains the 
consensus OXOXXPXXW and motif II contains the consensus OOCCXXLXXOG, 
where O is any hydrophobic residue and X is any residue. The remaining two motifs are 
less well defined but have stretches of nonpolar residues (Kouzarides et al., 1988)
IRS 1/TRS 1 o f HCMV. IRS1/TRS1 are HCMV US22 family members. 
IRS1/TRS1 are partially contained within the repeat elements of the short component of 
the HCMV genome. IRS 1 extends from an internal repeat element into the short unique 
domain while TRS 1 extends from a terminal repeat element into the short unique domain. 
Therefore, synthesis o f their mRNAs is controlled by repeated promoters and the two 
proteins share residues at their amino termini but differ in their carboxyl-terminal 
sequences. IRS 1/TRS1 have duplicating function. Therefore, only one of the two open 
reading frames is required for transient complementation o f ori-Lyt dependent viral DNA 
synthesis (Jones and Muzithras, 1992). Both mRNA and protein products of TRS l/IRS 1
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(pTRS 1/pIRS 1) can be detected in all phases of the viral replication cycle. pIRS 1 and 
pTRS 1 are present in both the nucleus and the cytoplasm during the immediate early and 
early phases o f the viral growth cycle, but are found predominately in the cytoplasm 
during late phases of viral growth (Romanowski and Shenk, 1997).
As stated earlier, TRS 1/IRS 1 are required for HCMV ori-Lyt DNA replication. 
TRS 1/IRS 1 cooperate with other immediate early regulatory proteins to promote 
expression o f the six replication fork proteins (Pari and Anders, 1993; Pari et al., 1993; 
Iskenderian, 1996; Kerry et al., 1996). IRSl/TRSl exhibit little activity as transcriptional 
transactivators on its own, but with IE1 and IE2 proteins expression can be enhanced 
from a variety o f promoters (Romanowski and Shenk, 1997). For example, both IRS 1 
and TRS 1 genes upregulate the activity of the polymerase accessory protein gene 
promoter (UL44) in the presence o f IE 1 and IE2 proteins, but do not transactivate it when 
transfected alone (Stasiak and Mokarski, 1992).
An additional immediate early gene product is encoded within the IRS 1 gene.
This gene product called pIRS l 263 is encoded within the 3' end o f the IRS1 gene and is in 
the same reading frame as the large pIRSl protein. Expression of the IRS l 263 gene is 
controlled by a promoter that resides within the IRS 1 open reading frame in the unique 
short region o f the viral genome. pIRS l263 accumulates to its highest level during the 
early phase o f HCMV infection. This protein resides in the nucleus and antagonizes the 
transcriptional activating capability o f pTRS 1 and pIRS 1. pIRS l263 may therefore serve 
as part o f a regulatory loop, preventing overexpression o f some early or late gene 
products, optimizing or perhaps slowing the process of viral replication (Romanowski 
and Shenk, 1997). Whatever its role, the effect of pIRS I263 on virus growth in cultured
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fibroblast cells is at best subtle because no clear phenotype was evident for a mutant 
lacking the IRS1 coding region (Jones and Muzithras, 1992).
pIRS 1 and pTRS 1 are also present in the HCMV virion. These proteins were not 
degraded when intact virions were treated with trypsin, suggesting that the proteins are 
localized inside the viral tegument (Romanowski et al., 1997). In contrast the pIRSl263 
was not detected in the virions (Romanowski and Shenk, 1997). Virion pIRSl and 
pTRS 1 can also activate expression of viral immediate early promoters in cooperation 
with pUL69 but not pUL82 (Romanowski et al., 1997). Both pUL69 and pUL82 are 
transcriptional regulatory proteins that are components of the HCMV tegument (Liu and 
Stinski, 1992; Winkler et al., 1994; Winkler and Stamminger, 1996). Therefore 
pIRSl/TRSl may assist in the activation of HCMV promoters as the DNA first reaches 
the nucleus (Romanowski et al., 1997).
Table 1. Homology between MCMV and HCMV US22 family genes.






M3 6 LTL36 transactivator
M36 Ex2 UL36 Ex2 transactivator
M36 Ext UL36 Ext transactivator
M43 UL43(P)C
m!28 Ex3 US22 transactivator
MI39 US22 cell tropism
M140 US23 cell tropism
M141 US24 cell tropism
m!42 US26 transactivator
m!43 US23 transactivator
a M and m denote MCMV genes with and without homology to HCMV genes, respectively. 
b UL and US indicate HCMV genes within unique long and unique short regions o f  the genome, 
respectively.
c Homolog to HCMV according to position in the genome. (Rawlinson, 1996).
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MCMV US22 family members. The HCMV US22 family members are contained 
within the US or the UL region of the genome. In MCMV, several ORFs have homology 
to the HCMV US22 family members (Table I). The MCMV US22 family members are 
arranged in a similar fashion as those found in HCMV, with two clusters o f tandemly 
repeated homologs at either end o f the genome (Fig. 4) (Rawlinson et al., 1996). The 
MCMV US22 family members located at the left side o f the genome are more similar to 
the HCMV UL family members, and include genes M23, m23.1, M24, m25 and M36 
(Fig. 4) (Rawlinson et. al., 1996). The MCMV US22 family members at the right side of 
the genome are more US-like and include genes m l28 and M139-ml43 (Fig. 4) 
(Kouzarides et al., 1988; Nicholas and Martin, 1994; Nicholas et al., 1996). Products of 
the US22 genes M139, M140 and M141 are nonessential for viral replication and are 
involved in MCMV cell tropism and pathogenesis (Cavanaugh et al., 1996; Hanson et al., 
1999; Menard, 2000). A mutant virus deleted o f M139-M141 replicates in NIH 3T3 
fibroblasts like wild type virus, but replicates three logsio lower in macrophages in vitro. 
This virus also replicates poorly in mouse spleen tissue that contains macrophages that 
are permissive for wildtype MCMV. However, when these splenic macrophages are 
depleted, replication is restored to wild type levels (Hanson et al., 1999). This suggests 
that M139, M140 or M141 individually or in combination, is involved in macrophage 
tropism. Single mutants deleted of M140 or M141 grow 2-3 logsio lower and 2 logsio 
lower respectively, in macrophages compared to wild type virus (Hanson et al., in press). 
In fibroblasts M l40 and M141 single deletion mutants grow similar to wild type vims. In 
vivo, the M l40 and M141 single deletion mutants are also attenuated for replication in 
target organs rich in macrophages (Hanson et al., in press). These data suggest that M140
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and M141 genes are both involved in regulating MCMV growth in macrophages. The 
possibility of M l39 involvement in macrophage tropism was eliminated since M l39 
mutant virus grows similar to wild type virus in macrophages and macrophage rich 
organs (Hanson et al., in press).
The MCMV US22 family member m l28 (ie2) is an immediate early protein that 
activates its own promoter as well as the IE1/IE3 promoter (Cardin et al., 1995).
MCMV Hind HI Map
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FIG 4. Map o f MCMV (Smith strain) denoting location o f US22 family genes. 
Members of the MCMV US22 family influence viral pathogenesis. The location 
of these genes within the genome is indicated as shaded boxes (Rawlinson, 1996). 
The US22 family members are arranged with two clusters of tandemly repeated 
homologs at either end of the genome. US22 family members located to the right 
side of the genome are more like HCMV US members while the members on the 
left side o f the genome are more similar to HCMV UL family members.
IE2 is dispensible for growth in NIH3T3 cells as well as in the mouse (Cardin et al., 
1995; Manning and Mocarski, 1998). M36 has homology to the US22 family member 
UL36 o f HCMV. HCMV UL36, also an immediate early gene product, assists in the 
transactivation of genes involved in viral DNA replication (Iskenderian, 1996).
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The US22 family members ml42-ml43 are essential for viral replication in 
fibroblasts (Cavanaugh, 1996; Menard et al., 2000). While a virus deleted of M139- 
M141 is able to grow in fibroblast cells to levels similar to wild type virus, a virus deleted 
of M139-ml43 is helper dependent (Cavanaugh et al., 1996). Also, when MCMV is 
mutated within m l42 or m l43, infectious virus does not result upon transfection of 
cultured cells with mutant viral DNA (Menard et al., 2000). Collectively, these data 
suggest that m l42 and m l43 are essential genes. The genes m l42-m l43 have homology 
to the IRS1/TRS1 transactivator genes of HCMV (Rawlinson, et ai., 1996). Based on 
homology, we hypothesize that ml42-ml43 are functional homologs to ERS1/TRS1. We 
test this hypothesis in this proposal.
MCMV Immediate Early Genes ml42 and ml43
US22 family members m l42 and ml43 have some homology to IRS1/TRS1 of 
HCMV, and are located within the Hind III I fragment of MCMV (Fig. 4). The ml42 
transcript corresponds to a 1.8 kb RNA and the ml43 transcript corresponds to a 3.8 kb 
transcript. The transcriptional start site of ml 42 and m l 43 genes have been identified by 
nuclease mapping. For the transcript mapping, a 5’ end probe was hybridized to RNA 
from NIH 3T3 fibroblast cells that were infected for either 3 hours (early times) or 24 
hours (late times). Analysis of the ml 43 transcript revealed two major protected bands of 
identical size at 3 hours post infection and 24 hours post infection. These bands 
correspond to the initiation of ml43 expression at nucleotides 202686 or 202694. For 
ml42, at early times a protected band was found which corresponds to a start site at 
nucleotide 200847. However, an additional minor band was found which corresponds to
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a start site at nucleotide 200848 (Fig. 5). This suggests an additional initiation site for 
m l42 expression (Fig. 6). At late times, the same bands w ere  present along with another 
protected band that may correspond to ml42c. The m!42c s ta r t site was not mapped in 
these studies (Fig. 6) (Hanson et al., 1999).
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FIG. 5. Map of the m l42 and ml43 proteins. The location of 
conserved US22 family motifs, and other predicted motifs are 
shown for A) m i42 and B) m l43. The locatio»n of the m l42 and 
m l43 genes within the MCMV genome are a lso  indicated, with 
the TATA Box, 5’ end of the transcript, and com m on restriction 
enzyme sites denoted. Numbers refer to nucl&otides within the 
MCMV genome.
Analysis for protein motifs show that in addition to th_e US22 motifs, m l42 has an 
acidic domain that is common to all herpesvirus transcriptioaal transactivators. The ORJF
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m l43 contains potential bipartite nuclear localization signals, as well as several N- 
glycosylation sites (Fig. 5).
In summary, genes m l42 and m l43 are members of the US22 gene family. This 
gene family is known for its biological importance, by influencing viral pathogenesis. 
Since m l42 and m l43 are required for viral DNA replication in fibroblast cells, the role 
they play during a MCMV infection is a vital one. Thus far, the m l42 and m l43 
transcripts have been identified, and their transcriptional start sites have been mapped. 
The experiments in this dissertation will give us more knowledge about these essential 
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FIG. 6. Transcripts originating from the MCMV m l42 and m l43 gene 
region. A. Potential m l42 and m l43 open reading frames (ORFs) are 
indicated by closed boxes. Overlapping ORFs are indicated above the 
closed boxes. The poly A, TATA box, and common restriction sites are 
denoted. Numbers refer to nucleotides within the MCMV genome. B. The 
position and sizes of the ml42 and m l43 transcripts (Hanson et al., 1999).
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CHAPTER H 
SUMMARY OF EXPERIMENTAL PLAN
As previously stated, ml42 and ml43 are members of the US22 gene family of 
HCMV. Some members o f this family, HCMV TRS 1/IRS land UL36, MCMV ie2, and 
some ORFs within the region of homology in HHV-6, encode transcriptional 
transactivators (Stasiak and Mocarski, 1992; Nicholas and Martin, 1994; Cardin et al., 
1995; Iskenderian et al., 1996). The genes ml42-ml43 also have homology to HCMV 
IRS 1/TRS1 which are involved in the activation o f viral early genes involved in viral 
DNA replication (Iskenderian et al., 1996). Furthermore, these genes are expressed at one 
hour post infection which suggests that they may be immediate early genes. Most of the 
betaherpesvirus immediate early gene products discovered to date function as 
transcriptional transactivators. Therefore it is likely that ml42 and/or m l43 are 
functional homologs o f IRS 1/TRS 1 and function as transcriptional transactivators.
The specific objectives of this study were:
1) To determine to which kinetic class the m l42 and m l43 genes belong: 
immediate early, early or late. In order to do this, NIH3T3 cells were infected in the 
presence of drug inhibitors that block MCMV replication at immediate early, and early 
times. The drug anisomycin blocks de novo protein synthesis, thus allowing the 
expression o f only the immediate early genes. The drug phosphonoformate prevents viral 
DNA replication, allowing the expression of only the early genes. Late genes are 
expressed in the absence o f drug inhibitors.
2) To generate polyclonal antisera against ml42 and ml43 proteins. Since the 
m l42 and the ml43 proteins have not been previously described, m !42 and ml43
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specific antiserum was needed. Therefore, m i42 and ml43 were cloned separately, in 
frame with a histidine tag. The histidine tagged ml42 and ml43 fusion proteins were 
expressed and then purified using a nickel-chelating column. Following purification the 
proteins were injected into rabbits for antibody production. Once the m l42 and ml43 
specific rabbit anti-serum was obtained, experiments were done to ensure the specificity 
of these antibodies.
3) To characterize the m l42 and ml43 proteins. Since the m l42 and ml43 
proteins have not been previously described, the size and expression kinetics of these 
proteins were determined. For the kinetics studies, NIH3T3 cells were infected with 
MCMV at an MOI of 2 for 0, 3, 6, 12, or 24 hours. Next lysates from these infected cells 
were analyzed by Western blot to determine the molecular weight and time o f expression 
of ml42 and ml43 proteins.
4) To determine the localization of ml 42 and ml 43 proteins within an MCMV 
infected cell. Since it was proposed that ml42 and/or ml43 are transcriptional 
transactivators, it was o f great interest to determine if they localize to the nucleus. In 
order to determine this, immunofluorescence assays were done to localize the m l42 and 
m l43 protein products to at least the nucleus or the cytoplasm. These 
immunofluorescence studies were performed at 24 hours post infection. Cell 
fractionation experiments allow the separation of the nuclear and cytoplasmic fractions of 
infected cells. This procedure was also used to determine if m l 42 and ml 43 localize to 
the nucleus or cytoplasm at various times post infection.
5) To determine the ability o f ml42 and ml43 to function as transcriptional 
transactivators. Gene products m l42 and ml43 could have several possible functions as
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transcriptional transactivators. The ml42 and m l43 gene products could a) transactivate 
the MCMV iel/ie3 promoter, b) transactivate the promoters o f MCMV early genes 
whose products participate in MCMV DNA replication, c) transactivate other early or 
late genes whose products do not function in MCMV DNA replication, or d) serve as a 
co-activator with IE1 and/or IE3 to enhance transcription of MCMV genes. We 
determined the transactivation function of m l42 and ml43 by testing their ability, 
individually and collectively, to activate selective MCMV promoters. First, it was 
determined if m l 42 and/or ml 43 can transactivate the iel/ie3 promoter. We also 
determined if m l42 and/or ml43 might serve as a co-activator of the iel/ie3 promoter 
along with EE1 and IE3. Our next goal was to determine if m l42 and/or ml43 can 
activate the promoter o f the MCMV early gene e l (M l 12-MI 13). The MCMV e l gene 
has homology to HCMV UL112-113, which is required for HCMV DNA replication 
(Pari and Anders, 1993). We also determined if m l42 and/or ml43 might serve as a co­
activator o f the el promoter along with EE1 and IE3.
Genes m l42 and m l43 are essential for viral DNA replication in fibroblasts cells. 
Therefore, these gene products play a vital role in the biology of MCMV. These studies 
are very important because they characterize these proteins that are necessary for viral 
growth, as well as assign a potential function to these proteins. This information will 
provide a foundation for studying the role o f these genes in the context o f a viral 
infection. In the future, ml42/ml43 mutant viruses will be generated for this purpose.
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CHAPTER IH 
MATERIALS AND METHODS 
Cell line
NIH 3T3 cells, a contact-inhibited murine fibroblast cell line from American Type 
Culture Collection (Rockville, MD), were propagated in Dulbecco’s Modified Eagle’s 
Medium (Mediatech, Herndon, VA) supplemented with 10% heat inactivated bovine calf 
serum (Hyclone Laboratories, Logan, UT) and 1% L-glutamine (Mediatech, Hemdon, 
VA).
Virus
The Smith strain o f murine cytomegalovirus (MCMV) was obtained from the 
American Type Culture Collection (Rockville, MD). Stocks of virus were prepared in 
and titered on NIH3T3 fibroblasts, as previously described (Campbell et al., 1989).
Plasmid constructions
Plasmid cloning was conducted by standard methods (Maniatis et al., 1987), and 
each plasmid was tested by restriction endonuclease digestion to ensure that the correct 
DNA sequences were inserted. The restriction endonuclease digestions were done 
according to manufacturer’s suggestions. The plasmids to be used for the transfection 
studies were prepared and purified using cesium chloride/ethidium bromide 
centrifugation (Current Protocols in Molecular Biology, 1998) or the Quantum Prep 
Plasmid Maxiprep Kit (Bio-Rad, Hercules, CA).
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Plasmids encoding MCMV immediate early proteins were kindly provided by Dr. 
Martin Messerle (Messerle et al., 1992). These include plasmid pp89UC, pIE3, and 
pIEl 11 that encode the MCMV immediate early proteins EE1, IE3, and IE1+IE3 
respectively. The plasmid pMCMV3CAT, which contains the MCMV iel/ie3 
promo ter/enhancer sequence upstream of the chloramphenicol acetyl transferase (CAT) 
gene and the plasmid el CAT, which contains the MCMV 112-113 promoter upstream of 
the CAT gene, were provided by Messerle as well.
Generation of ml 42/ ml 43 expression vectors. A construct expressing both ml 42 
and m l 43 genes, under the control o f their natural promoters, was generated for use in 
transient assays. This construct was made by digesting the Hind III I clone of MCMV 
with BsrGl (New England Biolabs, Beverly, MA) and Hind III (Promega, Madison, WI). 
Next, the 4.6 kb linearized molecule containing ml42-ml43 was isolated from a 5% 
acrylamide gel. The plasmid pSVZeo (Invitrogen, Carlsbad, CA) was linearized with 
Acc65I (MBI Fermentas, Amherst, NY), treated with calf intestine alkaline phosphatase 
(Boehringer Mannheim, Indianapolis, IN) for an hour, and gel purified. Since DNA 
digested with the enzymes BsrGl and Acc65I have compatible ends, the 4.6kb fragment 
containing m 142/m 143 was cloned into the Acc65I site of pSVZeo (Invitrogen, Carlsbad, 
CA). This constmct was called Zeo-I4.6.
The construct ZeoI-4.6 was not optimal for use in the transient assays, because of 
problems with high basal levels o f chloramphenicol acetyl transferase (CAT) activity in 
the CAT assays. Therefore, we generated another construct that expresses ml42-ml43 
under the control of their native promoters. In order to do this, the construct Zeo-I4.6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
40
was digested with Hind III and EcoRl, and the 4.6 kb insert was isolated from an 
acrylamide gel. The Hind III and EcoRI sites are located in the multiple cloning site of 
the pSVZeo vector (Invitrogen, Carlsbad, CA) on opposite sides o f the insert containing 
ml42/ml43. The vector pCDNA3.I was also digested with Hind III and EcoRl, 
followed by phosphatase treatment for an hour, and gel purification. The 4.6 kb fragment 
containing m l42/ml43 was cloned into the Hind III/ EcoRl site o f pCDNA3.1. This 
construct was called 142/I43pCDNA.
Generation of 142pCDNA and 143pCDNA expression vectors. Vectors 
expressing either m l42 (142pCDNA) or ml43 (143pCDNA) were also generated for use 
in transient assays. The 142pCDNA and 143pCDNA constructs were made by 
polymerase chain reaction. The primers used for the generation o f p 142 include MCMV 
sequences 200502-200517 for the forward primer (sequences TCTCCACCCGAATTC 
CCGCTGCCG) and MCMV sequences 199417-199442 for the reverse primer 
(sequences CGAGGCGATATCCCGTCCGTCCGTC). These primers were generated by 
Life Technologies (Rockville, MD). The 142/143pCDNA vector was used as the 
template DNA for PCR. The PCR product generated with the use of these primers (1.1 
kb) was digested with EcoRl and EcoRV. The expression vector pCDNA3.1 was also 
digested with EcoRl and EcoRV, and treated with phosphatase for an hour. The DNA 
fragments were run on a 5% polyacrylamide gel and eluted. The 1.1 kb fragment 
containing m l42 was then cloned into the pCDNA3.1 vector (Invitrogen, Carlsbad, CA) 
under the control of the HCMTV major immediate early promoter/enhancer (MIEPE), and 
this construct was called 142pCDNA.
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The 143pCDNA vector was also generated using PCR. The MCMV sequences 
202602-202626 were used as the forward primer (sequences TCCGCTCGAATTCGTC 
CGCCCGTC) and MCMV sequences 200873-200899 were used as the reverse primer 
(sequences GGGCGGGTGATATCAGAGATGACATG). These primer sequences were 
also generated by Life Technologies (Rockville, MD). The expression vector 
142/143pCDNA was used as the template DNA. The PCR product (1.7 kb) was then 
digested with EcoRl and EcoRV. The expression vector pCDNA3.1 (Invitrogen, 
Carlsbad, CA) was also digested with EcoRl and EcoRV, and phosphatase treated for an 
hour. The DNA fragments were run on a 5% polyacrylamide gel and eluted. The 1.7 kb 
fragment containing m l43 was then cloned into the pCDNA3.1 vector (Invitrogen, 
Carlsbad, CA) under the control o f the HCMV MIEPE and this construct was called 
143pCDNA.
Generation o f ml42pBad/HisA and m!43pBad/HisA. Constructs were generated 
that contain the m!42 or ml43 gene cloned in frame to sequences encoding the Xpress 
epitope and six histidine tags. These constructs were made using the pBADHisA vector 
(Invitrogen, Carlsbad, CA) in order to generate histidine-tagged m l42 or ml43 fusion 
proteins that would later serve as immunogens for the production o f ml 42 and ml 43 
polyclonal antisera. The polyhistidine tags allow purification of the recombinant fusion 
protein on a metal-chelating resin and the Xpress epitope permits detection of the 
recombinant fusion protein by the anti-Xpress antibody. This vector also allows the 
expression of the inserted gene to be strictly regulated. Expression from the plasmid 
pBADHisA (Invitrogen, Carlsbad, CA) occurs only in the presence of arabinose.
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In order to generate a construct containing the histidine and Xpress tagged m l43 
recombinant gene, the plasmid Zeo-I4.6 was digested with Kpnl (New England Biolabs, 
Beverly, MA). The plasmid Zeo-I4.6 contains both m l42 and ml43. Next the digest 
was run on an acrylamide gel and the 1.8 kb fragment (MCMV sequences 200526- 
202422) containing the m l43 open reading frame was eluted. The vector pBad/His A 
was digested with Kpnl (New England Biolabs, Beverly, MA) and treated with calf 
intestine alkaline phosphatase (Boehringer Mannheim, Indianapolis, IN) for an hour, then 
gel purified. The 1.8 kb fragment containing ml43 was ligated into the pBad/His A 
vector which was linearized with Kpnl. This construct was called ml 43 pBad/His A. The 
vector Zeo-I4.6 was also digested with Kpnl and EcoRl (Promega, Madison, WI) in 
order to generate a construct containing the histidine and Xpress tagged m l42 
recombinant gene. The 1.6 kb fragment (MCMV sequences 198878-200526) containing 
m l42 was eluted from an acrylamide gel. The vector pBad/HisA was digested with 
Kpnl and EcoRl, and treated with calf intestine alkaline phosphatase (Boehringer 
Mannheim, Indianapolis, IN) for an hour, then gel purified. The 1.6 kb fragment 
(containing m l42) was inserted into the pBad/HisA vector which was digested with Kpnl 
and EcoRl. This vector was called ml42pBad/HisA.
Procedures
Expression from ml42pBad/HisA and ml43pBad/HisA. The Kpnl-EcoRl 
fragment containing m l42 (MCMV sequences 198878-200526) or the Kpnl-Kpnl 
fragment containing m l43 (MCMV sequences 200526-202422) was cloned in frame to 
sequences encoding six polyhistidine tags and the Xpress epitope using the pBAD/HisA
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vector (see above). These plasmids were used to transform TOP 10 E. coli. In the 
presence o f arabinose, expression from pBAD/HisA is turned on while in the absence of 
arabinose very low levels o f transcription occur. Since each recombinant gene has 
different characteristics that may affect optimum expression, it was necessary to vary the 
arabinose concentration to determine the best condition for optimal expression o f ml42 
and ml43. The arabinose concentration was varied over a 10,000 fold range (0.00002%- 
0 .2%).
For both the pml42 and the pml43 TOP 10 transformants, the expression studies 
were performed as follows. Briefly, 2 ml o f  LB containing 50 pg/ml of ampicillin was 
inoculated with a single recombinant TOP 10 colony and incubated overnight at 37°C 
with vigorous shaking. The next day, 10 ml o f LB containing 50 pg/ml ampicillin was 
added to five tubes. Each tube was inoculated with 0.1 ml o f overnight culture and 
allowed to grow at 37° C to a 0.5 OD 6oo- Next, 20 % arabinose was added to each tube 
to give the following final concentrations o f  arabinose: 0.00002%, 0.0002%, 0.002%, 
0.02% and 0.2%. These cultures were grown at 37° C with shaking for 4 hours. From 
each culture a I ml aliquot of cells was taken. Next the cells were pelleted and the 
supernatant was removed by aspiration. The cell pellet was then frozen at -20° C. Each 
sample was resuspended in 100 pi of I x SDS-PAGE sample buffer and boiled for 5 
minutes. Each sample was then analyzed by Western blot using the anti-Xpress antibody 
(Invitrogen, Carlsbad, CA).
It was found that the optimal concentration for the expression of m l42 was 0.2% 
arabinose and the optimal concentration for the expression ml43 was 0.02% arabinose.
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Using the given concentrations o f arabinose, 250 ml cultures o f  the recombinant protein 
were prepared, and used for recombinant protein purification.
Initially we tried to purify the mI42 and ml43 protein products using only the 
Xpress™ purification system (Invitrogen, Carlsbad, CA). The Xpress purification system 
involves the lysis of Top 10 E. coli expressing ml42 or ml43 protein in guanidinium 
lysis buffer, removal of insoluble bacterial debris, purification o f  the recombinant protein 
using a metal chelating column, and elution of the histidine tagged m l 42 or m l 43 protein 
from the column. These attempts were unsuccessful because the m l42 and ml43 
proteins were insoluble proteins found in inclusion bodies, which were discarded with the 
bacterial debris. The m l42 and m l43 proteins were proven to be insoluble proteins when 
the pellet containing the bacterial debris was solubilized using the Inclusion Body 
Solubilization Reagent (Pierce, Rockford, IL) and analyzed by Western blot using the 
anti-Xpress antibody. Both m l42 and m l43 proteins were detected in the inclusion 
bodies using this method.
Therefore in order to correct for this problem, we used several different 
commercial reagents and followed the instructions detailed by the manufacturer. Top 10 
E. coli expressing ml42 or m l43 were pelleted, and lysed using the B-PER™ Bacterial 
Protein Extraction Reagent (Pierce, Rockford, IL). The bacterial lysate was then 
centrifuged and the precipitated protein was solubilized using the Inclusion Body 
Solubilization Reagent (Pierce, Rockford, IL). The proteins were then purified using the 
Xpress™ purification system (Invitrogen, Carlsbad, CA) under denaturing conditions. 
Using this system, the histidine tagged ml42 or ml43 fusion proteins were allowed to 
bind to a metal chelating column, and then eluted from the column. The eluted protein
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was then checked to make sure that m l42 or m l43 proteins were present by Western blot 
using the anti-Xpress antibody. As expected, a band o f  42 kD was detected for the 
histidine tagged m l42 recombinant protein and a band o f  56 kD was detected for the 
histidine tagged ml43 recombinant protein. The purified proteins were then sent to 
Cocalico Biologicals, Inc. (Reamstown, PA) for rabbit injection. Two rabbits were 
immunized with the same preparation o f recombinant protein.
Western Blot Analysis. Western blots were conducted as previously described 
(Pari and St. Jeor, 1990). Briefly, NIH3T3 cells were harvested in Western lysis buffer 
(50 mM Tris, 1% SDS, pH 7.5). The samples were subjected to SDS-PAGE on 12.5% 
gels, and transferred to nitrocellulose membranes (Boehringer Mannheim, Indianapolis, 
IN). The blots were treated with protein blocking solution containing 5% milk diluted in 
0.1% Tween 20/TBS (lOmM Tris, 150 mM NaCl) overnight at 4°C, and then incubated 
with a primary antibody for one hour at room temperature at a 1:100 dilution in milk (5% 
milk diluted in 0.1% Tween 20/TBS). The blots were washed three times in 0.1% Tween 
20/TBS at room temperature, and then incubated with a horseradish peroxidase (HRP)- 
conjugated secondary antibody (Sigma, St. Louis, MO) (diluted 1:10,000) in 5% milk for 
one hour at room temperature. Following three more washes in 0.1% Tween 20/TBS, 
antibody binding was detected by chemiluminescence using the ECL Western Blotting 
Detection Kit (Amersham Pharmacia Biotech, Arlington Heights, IL) on Fuji RX film.
DNA Transfection. Transient transfection experiments were done using the 
Transfast Reagent (Promega, Madison, WI). This reagent utilizes cationic liposomes to
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deliver nucleic acid to eukaryotic cells. Briefly, low passage NIH 3T3 cells were plated 
the day before transfection in 60 mm dishes at 3xl05 cells/dish. The Transfast Reagent 
(Promega, Madison, WI) was also suspended in nuclease free water the day prior to 
transfection. To suspend the Transfast, the vial of Transfast Reagent and nuclease free 
water were warmed to room temperature. The nuclease free water was added to the vial 
to create a volume of ImM of cationic lipid component (400 pi per 0.4 mg vial). After 
adding the nuclease free water, the sample was vortexed vigorously for 10 seconds to 
suspend the lipid film. The Transfast Reagent was then frozen at —20° C overnight. At 
the time of transfection, the vial of Transfast Reagent was warmed to room temperature. 
Serum free media and complete media (containing serum) were warmed to 37° C. The 
Transfast Reagent/DNA mixture was then prepared. A total of 5 pg o f plasmid DNA was 
added to 2 ml of serum free media and the mixture was vortexed briefly. Next a 1:1 
charge ratio of Transfast Reagent to DNA was added to the DNA mixture (15 pi 
Transfast per 5pg of DNA ) and vortexed immediately. The Transfast/DNA mixture was 
then allowed to incubate at room temperature for 10-15 minutes. After the incubation 
period, the DNA mixture was vortexed briefly. Next the medium was removed from the 
cells and the DNA mixture was added. The cells were then allowed to incubate at 37° C 
for one hour. At the end o f the incubation period, the cells were gently overlayed with 4 
mis o f complete media and returned to the incubator for 48 hours. The overall 
transfection efficiency using this method was about 10%.
Transfection /Superinfection. Since the NIH3T3 cells transfected using the 
Transfast reagent did not demonstrate cytopathic effect (CPE) subsequent to MCMV
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infection, transfection/superinfection experiments were done using the Cytofectene 
reagent (Bio-Rad, Hercules, CA). Approximately 3xl05NIH 3T3 fibroblast cells were 
seeded into 25 mm tissue culture flasks the day before transfection. Next the plasmid 
DNA/Cytofectene mix was prepared. First 9 pi o f Cytofectene mix was added to 100 pi 
o f Dulbecco’s Modified Eagle’s Medium (DMEM) per sample. This mix (mix I) was 
incubated at room temperature for 10 minutes. Next 6 pg o f plasmid DNA was mixed 
with 100 pi o f DMEM (mix 2). Next the Cytofectene solution (mix I) was added to the 
plasmid DNA solution (mix 2) and incubated at room temperature for ten minutes. This 
Cytofectene/DNA mix was then incubated at 4° C overnight.
The following day, the Cytofectene/DNA mix was allowed to reach room 
temperature. Next 2 ml o f complete 3T3 media were added to each Cytofectene/DNA 
sample and mixed. The cells were washed with sterile PBS and the Cytofectene/DNA 
mix was added to the cells. The cells were incubated for at least 5 hours at 37° C, the 
Cytofectene/DNA mix removed, the cells washed with PBS, and NIH 3T3 complete 
media added. After 24 hours post transfection, the cells were split 1:2 into a 60 mm dish. 
The following day the cells were infected with the appropriate multiplicity o f infection 
for one hour. Following the infection, complete medium was added to the cells.
Chloramphenicol Acetyl Transferase Assays. Approximately 3x10s NIH 3T3 
fibroblast cells were seeded into 60 mm tissue culture dishes the day before transfection. 
A total o f 5 pg o f plasmid (including the transcriptional transactivators and MCMV 
reporter-CAT constructs) were transfected into cells using the Transfast Reagent 
(Promega, Madison, WI) at the indicated concentration. The empty vector pCDNA3.1
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was used to maintain a constant amount of plasmid DNA per transfection. At 48 hours 
post-transfection, the cells were harvested. Briefly, the transfected cells were washed 
twice with 3 mis of Tris Buffered Saline (TBS)(30mM Tris, 150mM NaCl, pH 7.4), then 
scraped off the plates into 0.4 ml o f TBS. Next the cells were pelleted and resuspended 
in 100 pi of 0.25 M Tris-HCL pH 7.8. Following three rounds of freezing in an ethanol 
dry ice bath and thawing at 37° C, the cell lysates were centrifuged and the supernatants 
were transferred to new tubes. The extracts were then heated to 68° C for 10 minutes and 
the amount of protein per extract was determined using the BCA Protein Assay Kit 
(Pierce, Rockford, II). Equal amounts o f protein (15 pg of protein per sample) were used 
in each sample to be analyzed for CAT activity. The standard CAT assay contains 20 pi 
o f extract (containing 15 pg o f protein in 0.25 M Tris pH 7.8), 70 pi 0.25 M Tris pH 7.8, 
20 pi of 4 mM acetyl coenzyme A, 34 pi o f H2O, and O.lpCi of [14C] chloramphenicol 
(Amersham Pharmacia Biotech, Piscataway, NJ) in a reaction volume o f 125 pi. 
Reactions were carried out for 30 minutes at 37° C, extracted with ethyl acetate, and the 
extracted products were dried in a Speed Vacuum Concentrator. Reaction products were 
resuspended in 20 pi of ethyl acetate, spotted onto silica gel thin layer chromatography 
plates and the products were separated by ascending chromatography using 95:5 
chloroformrmethanol (190ml chloroform/10ml methanol). After autoradiography, each 
form o f chloramphenicol was quantitated using a Phosphorimager (Molecular Dynamics, 
Sunnyvale, CA). The reactions were linear for at least 30 minutes for up to 50% 
acetylation. When above 50% acetylation occurred during the 30 minute incubation, the 
assay was repeated using less protein. Experiments were repeated a minimum of three 
times and the average of three experiments were shown.
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Northern Blot Experiments. Approximately 1 x 1 0 6 NLH 3T3 cells were seeded 
into 100 mm tissue culture plates the day before infection. The fibroblasts were either 
mock infected or infected with wild type (WT) MCMV at a multiplicity of 2 PFU per 
cell. Following virus adsorption at 37° C for one hour, the inoculum was removed, and 
10 ml of culture media were added. For immediate early RNA isolation, 100pM 
anisomycin was added to the cells one hour prior to and during infection. For early RNA 
isolation, phosphonoformate was added to the culture media at a concentration of 300 pg 
per ml at the time of infection. For late RNA isolation, RNA was harvested from cultures 
at 24 hours after infection. Total RNA was harvested using the Qiagen Rneasy kit for 
total RNA isolation (Qiagen, Chatsworth, CA). Northern blots were conducted as 
described by Maniatis and coworkers (1987). RNA samples were quantitated at 260 nm, 
and 5 ug of each sample was loaded into the well of a 1.5% agarose/6.6% formaldehyde 
gel and electrophoresed overnight at 20 volts. The following day, the gels were rinsed 
three times in sterile distilled water (10 minutes per wash), and transferred to a 
positively-charged nylon membrane overnight in 20XSSC (3M NaCl, 300 mM sodium 
citrate, pH 7.0). In some cases the gels were treated to enhance transfer o f large RNA 
species by partial alkaline hydrolysis. This includes soaking for 30 min in 0.05 M 
NaOH/1.5 M NaCl followed by neutralization in 0.5 M Tris/1.5 M NaCl (pH 7.5) prior to 
blotting. After transfer, the membranes were UV cross-linked (150J), and baked at 80° 
for 30 minutes. The Boehringer Mannheim Genius System (Boehringer Mannheim, 
Indianapolis, IN) was used to detect hybridized probes of MCMV DNA labeled with 
digoxygenin-11-dUTP/dATP. Bands were visualized using the chemiluminescent
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substrate disodium3-(4-methoxyspiro{l,2-dioxetane-3,2’-(5’-chloro)tricyclo [3.3.1.13’7] 
decan}-4-yl) phenyl phosphate which is referred to as CSPD.
Cell Fractionation Experiments. The NE-PER Nuclear and Cytoplasmic 
Extraction Reagent (Pierce, Rockford, IL) was used to determine the localization of 
pm l42 and pm l43 within an MCMV infected cell. Approximately 1x 106NIH 3T3 cells 
were seeded into 100 mm tissue culture plates the day before infection. The fibroblasts 
were either mock infected or infected with wild type (WT) MCMV at a multiplicity of 5 
PFU per cell. Following virus adsorption at 37° C for one hour, the inoculum was 
removed, and 10 ml o f culture media were added. At the indicated time post infection, 
the cells were washed with sterile PBS, scraped from the plate, transferred to a 1.5 ml 
microcentrifuge tube, and pelleted. Next 100 pi of cytoplasmic extraction reagent 1 
(CER1) were added to the cell pellet and vortexed vigorously for 15 seconds. The tube 
was then placed on ice for 10 minutes. Next 11 pi o f CERII were added to the tube, 
vortexed, and placed on ice for 1 minute. After vortexing again, the tube was centrifuged 
for 5 minutes at maximum speed (16,000XG). The supernatant, which contains the 
cytoplasmic extract, was then transferred to another tube then placed on ice. The 
insoluble pellet was then resuspended in 100 pi of nuclear extraction reagent (NER) and 
vortexed for 15 seconds. The sample was then placed on ice and vortexed for 15 seconds 
every 10 minutes for a total of 40 minutes. The nuclear fraction was then centrifuged at 
16,000XG, and the supernatant, which contains the nuclear fraction, was removed. The 
samples were stored at —80° C until use.
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The nuclear and cytoplasmic fractions were analyzed by Western blot analysis 
using m l42 and m l43 polyclonal antisera as described above. As a control to ensure that 
minimal nuclear contamination o f the cytoplasmic fraction occurred, the antibody against 
phosphotyrosine phosphatase-PEST (PTP-PEST) was used in the Western blot detection. 
The PTP-PEST protein is a mouse cytoplasmic protein. The PTP-PEST antibody was 
kindly provided by Dr. M. Tremblay (Department of Biochemisty, McGill University, 
Montreal, Canada).
Immunofluorescence. Immunofluorescence was also used to determine the 
localization o f the m l42 and ml43 proteins. The day prior to infection approximately 
1x105NIH 3T3 cells were seeded per chamber on chambered slides. The next day these 
cells were either mock infected or infected with MCMV at an MOI of 5 for an hour at 37° 
C, the viral inoculum removed, complete media added, and the cells incubated for 24 
hours at 37° C. After the 24 hour incubation, the growth medium was removed and the 
cells were washed two times with PBS containing Ca2_r and Mg2+. Cells were fixed in 2% 
paraformaldehyde (diluted in PBS, pH 7.4) for 10 minutes at room temperature. 
Following fixation, the cells were rinsed twice with Ca2+/M g2-r free PBS, and 
permeabilized with PBS containing 0.5% triton X 100 for 8 minutes at room temperature. 
The slides were stored at 4° C overnight. For the staining procedure, the cells were first 
rehydrated in 0.1% bovine serum albumin (BSA)/PBS. Next the primary antibody (anti- 
142 or anti-143) was added to the slides at several dilutions (1:100, 1:1000) in 0.1% 
BSA/PBS, and the slides incubated for one hour at 37° C. Control chambers were 
incubated with preimmune serum in 0.1% BSA/PBS at the same dilutions. As a positive
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control, the e l antibody was used (obtained from Dr. Gina Ciocco-Schmitt, Eastern 
Virginia Medical School, Norfolk, VA). Following primary antibody, the cells were 
washed three times with 0.1% BSA/PBS, and incubated with goat anti-rabbit antiserum 
conjugated with FITC (Sigma, St. Louis, MO) at a 1:100 dilution for 1 hour at 37° C.
The slides were washed twice with 0.1% BSA/PBS, once with distilled water, and then 
air dried. The coverslips were mounted on the slides with mounting fluid and viewed 
under a confocal microscope (Olympus Fluoview 100). Different Z-series o f the images 
were taken at 1-pM intervals and projected onto a single plane.




Kinetics of m l42 and ml43 Transcript Expression
Since m!42 and ml43 are essential genes, we wanted to determine at what time 
during viral infection m l42 and m l43 are expressed. In order to do this, a time course 
experiment was done. In this experiment RNA was harvested from NIH3T3 infected 
cells at 0, 1, 3, 6, and 16 hours after infection. This RNA was then analyzed by Northern 
blot using a DNA probe containing the Sst-Sst fragment o f MCMV from this region (Fig. 
6) (Hanson et al., 1999).
The ml42 and m l43 genes were expressed by one hour post infection, and reach 
maximal levels by three hours post infection. The ml42 transcript corresponds to a 1.8 
kb RNA and the m l43 transcript corresponds to a 3.8 kb RNA (Fig. 6B. and 7). Levels 
of these transcripts remained abundant at six and sixteen hours post infection (Hanson et 
al., 1999). It appears that the 1.8 kb m l42 transcript may shift to a 1.6 kb RNA species 
as time progresses, since at late times a 1.6 kb ml42 band predominates over the 1.8 kb 
band (Fig. 7 ). This could be explained by a variation in the size o f  the polyadenylation 
signal. Alternatively, the shorter 1.6 kb transcript may be generated by splicing, since 
splice donor and acceptor sites are dispersed throughout this gene. However, nuclease 
mapping would have to be done to confirm this. According to the expected size of the 
ml42b transcript, the 1.6 kb band could also be transcribed from m l42b (Fig. 6) (Hanson 
et al., 1999).
The Sstl-Sstl probe contains 404 nucleotides of the M141 gene. Therefore, the 
7.0 kb M l41 transcript was detected as well. The 5.1 kb transcript was expressed from
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FIG 7. Time course of expression of m l42 and ml43 transcripts. NIH 3T3 
fibroblast cells were either mock infected (M) or infected with 5 PFU/cell of wild 
type MCMV for the indicated times (hours post infection). RNA was isolated as 
described in the Materials and Methods. The gel was treated by partial alkaline 
hydrolysis to enhance transfer of larger RNA species and probed with a labeled 
probe spanning the m l42 and ml43 gene region. Numbers to the left denote sizes 
(Kb) (Hanson et al., 1999).
ml44. Although the Sstl-Sstl probe is outside o f the m l44 gene region, the ml44 
transcript was detected because ml42, ml43 and m I44 have 3’ coterminal transcripts 
(Hanson et al., 1996).
ml42 and ml43 Are Immediate Early Genes
Since m l42 and m l43 were expressed at one-hour post infection, we speculated 
that these might be novel immediate early genes not previously identified. By definition, 
immediate early genes are those expressed in the absence of de novo protein synthesis.
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The drug anisomycin prevents de novo protein synthesis thus allowing the expression of 
only the immediate early genes during an MCMV infection.
We therefore determined if ml 42 and ml 43 are true immediate early genes. In 
order to do this, NIH 3T3 fibroblast cells were infected in the presence o f anisomycin. 
Under these conditions, both m l42 and ml43 were detected when a probe containing the 
Sst I-Sst I fragment o f MCMV corresponding to this region was used (Fig. 6A, 8). 
Therefore, m l42 and m l43 are true immediate early genes (Fig. 6B, Fig. 8). Under these 
conditions MCMV IE1 and IE3 are abundantly expressed, while early genes like m l44 
are absent (data not shown). This proves that the anisomycin treatment was effective in 
that only the immediate early genes were expressed.
These genes were also expressed in the presence of the viral DNA replication 
inhibitor phosphonoformate, suggesting that these genes are also expressed at early times. 
At early times, it was also evident that a 1.6 kb and a 2.2 kb transcript were expressed 
(Fig. 8) (Hanson et al., 1999). Both m l42 and ml43 were expressed at late times of 
MCMV infection as well (24 hours post infection) (Fig. 8). Therefore m l42 and m l43 
are true immediate early genes, and are also expressed at early and late times of MCMV 
infection.
We were surprised to find that the expression of m l42 and m l43 is very different 
from the expression o f the other MCMV immediate early genes. For example, the 
immediate early genes iel and ie3 are expressed at abundant levels in the presence of the 
protein synthesis inhibitor cycloheximide (Messerle et al., 1991). However MCMV IE 
transcripts iel and ie3 are absent when NIH 3T3 cells are infected in the presence of the 
DNA replication inhibitor phosphonoacetic acid, and therefore do not accumulate at early
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mFIG. 8. m l42 and m l43 are newly identified genes expressed at 
immediate early times. NIH 3T3 fibroblasts were infected with 
2 PFU MCMV/cell and RNA was isolated. Immediate early (IE)
RNA was produced in the presence o f 100 pM anisomycin, early (E) 
RNA was produced in the presence o f 300 ug/ml of phosphonoformate, 
and late (L) RNA was harvested 24 hours post infection. A labeled 
probe spanning the m l42 and ml43 gene region (Sstl-Sstl) of MCMV 
Hind III I was used to detect transcripts from this region (see figure 6). 
The 3.8 kb transcript corresponds to ml43; the 1.8 kb transcript 
corresponds to m l42 (Hanson et al., 1999).
times (Messerle et al., 1991; Keil et al., 1987; Koszinowski, 1986). This suggests that 
unlike IE1 and IE3, m l42 and m l43 proteins may have important functions not only at 
immediate early times, but at all stages of viral infection.
The expression kinetics of m l42 and ml43 are most like the immediate early 
genes IRS1/TRS1 and UL36-38 o f HCMV. In HCMV, the IRS1/TRS1 and UL36-38 
genes are expressed in the presence of anisomycin. These genes are also abundantly 
expressed in the presence of phosphonoacetic acid (Romano wski and Shenk, 1997, 
Tenney and Colberg-Poley, 1991a, Tenney and Colberg-Poley, 1991b). The IRS 1/TRS1 
and UL36-38 proteins are involved in ori lyt dependent replication o f HCMV, and
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function as transcriptional transactivators. Interestingly, genes m l42 and ml43 have 
homology to the HCMV IRS1/TRS1 genes (Rawlinson et al., 1996) suggesting that ml42 
and mI43 gene products may have a similar function.
Characterization of pm l42 and pml43
Generation o f m !42 and m!43 Polyclonal Antibodies. The above experiments 
indicated that m l42 and m l43 are tme immediate early genes in that their transcripts are 
expressed in the absence o f  de novo protein synthesis. It was logical to assume that their 
protein products are also expressed at immediate early times, and like the transcripts, are 
upregulated at early and late times. Therefore, we proceeded to characterize the 
expression o f the m l42 and ml43 gene products in MCMV infected fibroblasts. In order 
to do this, antibodies specific for ml42 and ml43 protein products were generated. To 
serve as an immunogen for production o f the polyclonal antisera, histidine tagged fusion 
proteins were made as bacterially expressed proteins. The pBADHisA vector 
(Invitrogen, Carlsbad,CA) was used to generate these fusion proteins. This vector allows 
the m l42 and m l43 protein products to be fused to six histidine residues which comprise 
a polyhistidine tag and the Xpress epitope. The polyhistidine tags allow purification of 
the recombinant fusion protein on a metal-chelating resin and the Xpress epitope permits 
detection o f the recombinant fusion protein by the anti-Xpress antibody. This vector also 
allows the expression o f the proteins to be strictly regulated. Expression from the 
plasmid pBADHis A only occurs in the presence o f arabinose.
In order to generate histidine tagged ml42 and m l43 proteins, the 142 and 143 
genes were cloned into the pBADHis A vector. A Kpnl-BsrGl fragment (nucleotide
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sequences 200526-198878) o f the Hind HI I genomic region of MCMV was cloned into 
pBAD/His A in order to express a portion o f ml42 (Fig. 6). This construct does not 
include the first 222 bases o f the m l42 gene, and was called ml42pBAD/HisA. 
Remaining in this construct are US22 motifs III and IV within ml42, as well as the acidic 
domains (Fig. 5). A K pnl-K pnl fragment o f the Hind III I genomic region of MCMV 
(nucleotide sequences 202422-200526) (Fig. 6) was cloned into the pBAD/His A vector 
in order to express a truncated ml43 protein. The truncated ml43 gene is missing 171 
bases from the 5’ end. This construct, which was called ml43pBAD/HisA, includes the 
putative US22 family motifs I, HI and IV, the nuclear localization signals, and the N- 
glycosylation sites within the ml43 open reading frame (Fig. 5). These constructs were 
tested by restriction enzyme digestion to confirm that the correct MCMV sequence was 
inserted, and that the MCMV sequence was in the proper orientation.
Next it was necessary to determine if the recombinant m l42 and m l43 proteins 
were expressed from their respective expression vectors and to determine the optimal 
concentration of arabinose needed for their expression. In order to do this, 
ml42pBAD/HisA and ml43pBAD/HisA were transformed into TOP 10 E. coli. Next 
various arabinose concentrations were used to determine if protein expression was 
induced from these vectors. According to the DNA sequence, the expected size for the 
m l42 recombinant protein was 44 kD. At an arabinose concentration of 0.2 %, a protein 
o f 42 kD was expressed from the ml42pBAD/HisA vector (Fig. 9). The predicted size 
for the histidine tagged m l43 was 59 kD. At arabinose concentrations of 0.002% and 
0.02%, a 56 kD protein was induced from the ml43pBAD/HisA vector (Fig. 9). These
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data indicate that the histidine tagged m l42 and m l43 proteins are expressed from their 
respective expression vectors and are similar to their expected size.
his 142 hisl43
^  ®\° o\a . .
Arabinose ^  ^  ^  ^  ^  
cone: v  56
FIG. 9. Expression of the histidine tagged recombinant ml42 and ml43 proteins. 
Top 10 E.coli containing ml42BAD/HisA or ml43BAD/HisA were incubated 
with various arabinose concentrations. The bacterial pellet was then lysed and 
analyzed by Western blot as described in the Materials and Methods using the 
Anti-Xpress Antibody. Sizes of molecular weight markers are indicated on the 
right.
Since the histidine tagged m l42 and m l43 proteins were expressed from their 
respective expression vectors, our next goal was to purify these proteins from bacterial 
cells. In order to do this, 250 ml cultures of bacteria containing ml42pBAD/HisA and 
ml43pBAD/HisA were grown, induced with arabinose, and used for recombinant protein 
purification. Several attempts were made to purify the recombinant ml42 and ml43 
proteins from the bacterial lysate using the Invitrogen Xpress Purification System. This 
method was unsuccessful at first because the m l42 and ml43 recombinant proteins 
proved to accumulate in inclusion bodies that were discarded with the bacterial debris. 
Inclusion bodies are very dense aggregates of insoluble protein that contain most of the
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expressed protein. Our next approach was to lyse the cells, purify the inclusion bodies, 
solubilize the inclusion bodies, and then purify the recombinant protein. The cells were 
lysed and the inclusion body was purified using the B-PER Bacterial Protein Extraction 
Reagent (Pierce, Rockford, IL). This reagent allows gentle and complete lysis o f the 
bacterial cells, and purification o f the inclusion bodies. The inclusion bodies were then 
solubilized using the Inclusion Body Solubilization Reagent (Pierce). The Inclusion 
Body Solubilization Reagent moves the insoluble inclusion body into solution, thus 
allowing purification o f the recombinant protein. Finally the proteins were purified using 
the Xpress Purification System (Invitrogen, Carlsbad, CA). In this system the 
recombinant proteins, which were tagged with six histidines, were purified with a metal 
chelating column and then eluted from the column. The polyhistidine tag functions as a 
metal-binding site for affinity purification o f the recombinant fusion protein on the metal- 
chelating resin. The eluted proteins were then checked to make sure that m l42 and m l43 
proteins were present by Western blot analysis using the anti-Xpress antibody. As 
expected, a band o f  42 kD was detected for the histidine tagged m l42 recombinant 
protein and a band o f  56 kD was detected for the histidine tagged ml43 recombinant 
protein (data not shown). The purified proteins were then sent to Cocalico Biologicals, 
Inc. (Reamstown, PA) for rabbit injection. Exsanguination of the rabbits took place 
following a two month period, which included four immunizations with the purified 
recombinant protein.
Once the polyclonal antisera were obtained, it was necessary to test them for their 
ability to recognize the m l42 and m l43 proteins. MCMV lysates from fibroblast cells 
that had been either mock infected or infected for 24 hours with MCMV at an MOI of 2
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were used to screen the rabbit serum by Western blot analysis for specificity of the 
antibody. Specific bands were seen in the infected cell lysates, but not in the mock 
infected cell lysates when both m l42 and m l43 antiserum were used. The m l42 protein 
corresponds to a 43 kD band, whereas the m l43 protein corresponds to a 53 kD band 
(Fig. 10). The m l42 protein product will be called pml42 and the m l43 protein product 
will be called pml43. The expected size o f pml42 according to its DNA sequence is 48 
kD, and the expected size o f pm!43 according to its DNA sequence is 64 kD. The 142 
and 143 proteins may be smaller than expected due to rapid post translational 
modification such as proteolytic processing of the proteins, although there is no evidence 
that this is taking place. The m l42 transcript shifts from 1.8 kb to 1.6 kb as time 
progresses, suggesting that splicing may occur which could account for the smaller size 
o f this protein. However nuclease mapping studies have not yet been done to confirm 
this (Hanson et al., 1999). There is also precedence for proteins with a high proportion of 
basic or charged amino acids to migrate faster or slower than their actual molecular 
weight on a polyacrylamide gel (Takano et al., 1988). Since both pm l42 and pml43 
have a high content of charged residues, they could be running faster on the 
polyacrylamide gel. This phenomenon could explain why pml42 and pml43 appear to 
be smaller than expected.
Another approach was used to confirm that the 43 and 53 kd proteins originate 
from ORFs m l42 and ml43, respectively. This approach utilizes transient transfection of 
m l42 or m l43 expression plasmids into cells, followed by Western blot analysis of cell 
lysates using pm l42 and pml43 antisera to determine ifpm l42 and pml43 are 
recognized. To generate the m l42 and ml43 expression plasmids, the full length ml42
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FIG. 10. m l42 and ml43 polyclonal antisera specifically recognize the pml42 
and pm 143 proteins, respectively. NIH 3T3 fibroblast cells were mock infected 
(M) or infected with wildtype MCMV (WT) at an MOI of 2 for 24 hours. Lysates 
were then analyzed by Western blot (as described in the Materials and Methods) 
using A.) the pml42 or B.) the pml43 antibody. Sizes o f molecular weight 
markers are indicated on the left.
and ml43 genes were cloned into the pCDNA3.1 expression vector using the 
polymerase chain reaction (PCR). The vector pCDNA3.1 was used because it is 
designed for high level expression of the gene o f interest in mammalian cells. This high 
level of expression is achieved because of the presence of the HCMV major immediate 
early gene (UL123) enhancer and promoter. This vector also contains the bovine growth 
hormone polyadenylation signal and transcription termination sequence to enhance 
mRNA stability. The expression plasmid 142pCDNA contains the m l42 gene and the 
expression plasmid 143pCDNA contains the m l43 gene. NIH 3T3 fibroblast cells were
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FIG. I I .  m l42 and m l43 polyclonal antisera recognize proteins 
expressed from the m l42 and ml43 genes respectively. NIH 3T3 
cells were m ock transfected or transfected with a plasmid containing 
the m l43 or the m l42 gene using the Cytofectine Reagent (Bio-Rad) 
as described in the Materials and Methods. Lysates were then analyzed 
by Western blot as described in the Materials and Methods using an 
antibody mixture containing pm 142 and pm 143 antisera. Lysates from 
wild type MCMV infected cells (WT) serve as a positive control.
transfected with the expression plasmid 142pCDNA or the expression plasmid 
143pCDNA. Lysates from these cells were analyzed by Western blot using a mixture of 
pm l42 and pml43 antisera. The specificity of the antibodies for the m l42 and ml43 
gene products was confirmed. The antibody against pm 142 reacted with a 43 kD protein 
product o f 142pCDNA and likewise the antibody against pm 143 reacted with a 53 kD 
protein product o f 143pCDNA in transfected cell lysates (Fig. 11). Therefore, the 43 kD 
and 53 kD proteins recognized by the pm l42 and pml43 antisera are products of the 
m l42 and m l43 genes, respectively.
Kinetics of the pm 142 and pm 143 proteins. As previously described, the ml 42 
and m.143 transcripts are present at immediate early times and remain abundant 
throughout infection. Prior to these studies the m l42 and m l43 protein products had not
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been identified. Therefore our next goal was to characterize these proteins. Since the 
142 and 143 transcripts are present at EE, E, and late times, we also expected to see their 
respective protein products at immediate early, early, and late times. To determine if  this 
occurs, a time course experiment was done in which fibroblast cells were infected with 
wild type MCMV at an MOI of 2 for 0, 3, 6, 12 and 24 hours. These lysates were 
analyzed by Western blot using a mixture of pml42 and pml43 antibodies. The results 
are shown in Figure 12. The ml42 protein product (43 kD) was present at 3 hours post 
infection as expected, although at low levels. The levels increased between 3 and 6 hours 
post infection, and remained abundant at 12 and 24 hours post infection. To our surprise, 
it was found that pm 143 (53 kD) was not detected at 3 hours post infection as expected 
for an IE protein, even after a prolonged exposure of film. However after increasing the 
MOI to 5 in subsequent experiments, pm 143 was also readily detectable at 3 hours post 
infection (see below). Therefore, these proteins appear to be regulated with similar 
kinetics.
The kinetics of pml42 and pm!43 expression is very different from that of the 
MCMV IE1 and IE3 proteins. The IE1 and IE3 proteins are present by 2 hours post 
infection and then gradually decrease at 4, 8, 12, 16 and 24 hours post infection (Messerle 
et al., 1992). At the protein level, pm l42 and pml43 are most similar to the HCMV 
immediate early proteins IRS 1/TRS1. These proteins are expressed at 2 hours post 
infection and remain throughout the entire HCMV replication cycle at relatively high 
levels (Romanwoski and Shenk, 1997). The IE proteins IRS 1/TRS 1 function at early 
times as transcriptional
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FIG. 12. Kinetics of pm!42 and pml43 protein expression. NIH 3T3 
fibroblast cells were infected with wild type MCMV at an MOI o f 2 for 
0, 3, 6, 12, and 24 hours. Lysates were analyzed by Western blot as 
described in the Materials and Methods using a mixture containing both 
pm l42 and pml43 antibodies. Asterisks denote low levels o f pm l42 
expression.
transactivators of genes required for viral DNA replication. This potential function will 
be considered for pm 142 and pm 143.
pm 142 and pm 143 are not immediate early proteins. Proteins pm 142 and pm 143 
were expressed at 3 hours post infection. Therefore they were expressed at a time that is 
at the borderline between an immediate early protein and an early protein. The 
designation immediate early or early cannot be assigned to pm 142 and pm 143 based on 
the time course that was performed previously. This designation can only be assigned to 
pm 142 and pm 143 by using drug blocks at specific stages within the viral replication 
cycle. To determine if a protein is expressed at immediate early times, cells must first be 
infected in the presence of the protein synthesis inhibitor anisomycin. Under these 
conditions only the transcripts that are made in the absence of de novo protein synthesis
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are expressed, the immediate early transcripts. The cells are then washed to remove the 
anisomycin, then actinomycin D is added. Actinomycin D prevents additional 
transcription of early genes from occurring. Therefore, only the immediate early 
transcripts made previously will be translated into protein, resulting in the expression of 
only the immediate early proteins.
T r e a t m e n t :  None Anm/ActD Anm/ActD
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-  89 kD
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FIG. 13. Immediate early genes m l42 and ml43 do not encode detectable 
immediate early proteins. NIH 3T3 fibroblast cells were incubated in the 
presence o f 100 pM anisomycin (Anm) for one hour, then mock infected 
(M) or infected with wild type MCMV (WT) for 3 hours at an MOI of 5 in 
the presence of 100 pM anisomycin. The cells were then washed with PBS, 
then incubated in the presence of 10 pg/ml of actinomycin D (ActD) for 6 
hours. The lysates were harvested and analyzed by Western blot using an 
antibody mixture containing both pm 142 and pm 143 antibodies. Lysates 
from cells infected in the absence of drugs serve as a positive control. As 
a control to confirm the drug blocks were effective, the Anm/ActD lysates 
were also probed with the IE 1 antibody. The IE 1 antibody was kindly provided 
by Ulrich Koszinowski (Department of Microbiology, Federal Research 
Center for Virus Diseases in Animals, Federal Republic of Germany).
We wanted to determine if pml42 and pml43 are immediate early proteins. In 
order to do this, NIH 3T3 cells were incubated for an hour in the presence of lOOpM 
anisomycin. Next these cells were either mock infected or infected with MCMV at a
53 kD -« 
43 kD -«
Infection: w j  jyj w y
a  m !42 + m l43
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MOI o f 5 in the presence o f  IOOjjM  anisomycin for 3 hours. The cells were then washed 
with PBS, and incubated in the presence o f 10 pg/ml of actinomycin D for 6 hours. The 
lysates were harvested and analyzed by Western blot using an antibody mixture 
containing both pm l42 and pml43 antibodies. Neither pm l42 nor pml43 was detected 
in this assay (Fig. 13). The immediate early protein IE1 was detected under these 
conditions, although at low levels. By definition, pm 142 and pm 143 are therefore 
classified as early proteins. Since pm 142 and pm 143 were present at 3 hours post 
infection in the protein kinetics experiment, which is borderline between IE and E, these 
data were not surprising.
The MCMV immediate early proteins IE 1 and IE3 should be expressed at 
abundant levels under the conditions described above (anisomycin/actinomycin D).
Since the immediate early transcripts were allowed to accumulate in the presence of the 
anisomycin, the level o f IE protein should be more abundant in the drug treated cells 
(anisomycin/actinomycin D), than cells not treated with drugs. Since the levels of IE I in 
the anisomycin/actinomycin D treated lysates were very low, this indicates that a 
technical problem may have occurred with this assay. For example, it is possible that the 
anisomycin was not completely removed. To assess this, lysates from cells infected in 
the absence o f drugs should be used as a control in future experiments.
Our results have shown that genes m l42 and m l43 express RNA at immediate 
early times of viral infection. However, pm 142 and pm 143 are expressed at early times. 
Therefore we hypothesize that there is translational control of m l42 and ml43 RNA.
One possible reason for translational regulation of pm 142 and pm 143 is that the proteins 
may be needed immediately following IE protein expression. The presence o f the ml42
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and m l43 transcripts at IE times could allow the rapid synthesis of these proteins at early 
times, without the need for m!42 and ml43 transcription.
Localization of the pml42 and pml43 proteins
As previously stated ml42 and ml43 are immediate early genes that encode early 
proteins, and are members o f the US22 gene family of HCMV. Although the function of 
most US22 gene family members is unknown, certain members of the family encode 
transcriptional transactivators. Also, ml42 and m l43 are homologous to the IRS 1/TRS 1 
proteins of HCMV, and are regulated similarly to IRS 1/TRS 1. IRS 1/TRS 1 are involved 
in the regulation of genes active during viral DNA replication. Therefore, it is likely that 
pm l42 and pml43 are transcriptional transactivators. In order for pml42 and pml43 to 
be transcriptional transactivators, they need to localize to the nucleus. Sequence analysis 
suggests that this is possible for at least pml43, because pml43 has several nuclear 
targeting signals. In contrast, pm 142 does not contain any nuclear localization signals 
(Fig- 5).
Localization of viral proteins in an MCMV infected cell can be tested in several 
different ways, for example by immunofluorescence studies. In this case, infected cells 
are fixed to glass slides then stained with a primary antibody against the protein of 
interest. Next the primary antibody is replaced with a secondary antibody that will 
recognize the primary antibody. The secondary antibody is conjugated to a label such as 
fluorescein isothiocyanate (FITC). This FITC label will provide a colored reagent that 
can be observed directly under a fluorescent microscope. Alternatively, the protein o f 
interest can be fused to the green fluorescent protein (GFP). In this case GFP serves as a
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reporter molecule for monitoring protein localization in transfected cells in vitro, since 
the protein fluoresces green when exposed to ultraviolet light. It is possible however that 
the GFP molecule may mask any nuclear localization signals or alter the structure of the 
protein o f interest, thus interfering with the localization of the protein. Other viral 
proteins that may be important in the localization of the protein of interest may be absent 
when using GFP-fiision proteins. This limitation can be overcome however by doing 
transfections with the GFP fusion plasmid, followed by superinfection with MCMV. 
Lastly, localization of viral proteins can be tested by performing cell fractionation 
experiments. In these experiments the nuclear fraction of a cell is separated from the 
cytoplasmic fraction. These fractions are then analyzed by Western blot using an 
antibody against the protein of interest to determine localization o f the protein.
We decided to use immunofluorescence to determine the localization o f the 
pm 142 and pm 143 proteins. Immunofluorescence is a very powerful tool, since it allows 
the localization of the protein of interest to be determined while maintaining the integrity 
of the infected cell. NIH 3T3 cells were infected with wild type MCMV at an MOI of 5 
for 6 hours or 24 hours. Following infection, the cells were fixed with paraformaldehyde 
then stained with pml42 or pml43 antiserum as the primary antibody (Fig. 14A,B). As a 
positive control, the antibody against e l, a nuclear localized protein, was used (Fig. 14D). 
Rabbit preimmune serum was used as a negative control (Fig. 14C). Following primary 
antibody staining, FITC conjugated goat anti-rabbit antibody was used as the secondary 
antibody (see Materials and Methods). There was no e l, pm 142 or pm 143 antibody 
signal observed when cells were infected for 6 hours (data not shown). This is
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FIG. 14. Immunofluorescense analysis of the pm!42 and pm l43.
NIH 3T3 fibroblasts were infected with MCMV at an MOI o f 5 for 
24 hours. Immunofluorescent staining was performed as described 
in the Materials and Methods using A. pm!42 antibody or B. pm 143 
antibody. As a negative control (C.) preimmune serum was used. As 
a positive control (D.) e l antibody was kindly provided by Dr. Gina 
Ciocco-Smitt (Department o f Microbiology and Molecular Cell Biology, 
Eastern Virginia Medical School, Norfolk, VA).
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likely due to the fact that not enough viral protein was present in the infected cell at 6 
hours post infection to be detectable in this assay. However at 24 hours post infection, 
the pm 142 protein localized predominantly to the cytoplasm, although low levels of 
pml42 protein were present in the nucleus (Fig. 14A). It was shown that pm.143 also 
localized to the cytoplasm predominantly, with very small amounts in the nucleus (Fig. 
14B). Although the presence of low levels of nuclear pml42 and pml43 were not 
obvious in figure 14, it was more visible in the cross-sectional images of the infected 
cells (data not shown). The cross-sectional images allow the cells to be viewed at 
different depths or sections, thus allowing the nucleus to be viewed without interference 
from the cytoplasmic components. Figure 14 is a representative picture of all o f the 
sections combined, therefore the nuclear staining that was observed may not be evident in 
this image.
We also used cell fractionation experiments to determine the localization of 
pm 142 and pm 143. These experiments allow the nuclear and the cytoplasmic fraction of 
infected cells to be separated and analyzed by Western blot with antisera against the 
protein of interest. This allows the localization of the protein to at least the nuclear or the 
cytoplasmic fraction to be determined. For the cell fractionation experiments, NIH 3T3 
fibroblast cells were infected with MCMV at an MOI o f 5 for 3 and 4 hours. Then the 
NE-PER Nuclear and Cytoplasmic Extraction Reagent was used (Pierce, Rockford, IL) as 
described in the Materials and Methods. It was determined that pm!42 localizes to both 
the nucleus and the cytoplasm at 3 and 4 hours post infection, and it appears that there is 
approximately equal distribution of pml42 in both fractions (Fig. 15A). Although in the
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FIG. 15. pm 142 and pm 143 proteins localize to the nucleus and the cytoplasm 
at 3 and 4 hours post infection. A). NIH 3T3 fibroblast cells were infected with 
MCMV at an MOI of 5 for 3 or 4 hours. The NE-Per Nuclear and Cytoplasmic 
Extraction Reagent (Pierce) was used as described in the Materials and Methods 
to separate the nuclear (N) and the cytoplasmic (C) fractions of the infected cells. 
Lysates were then analyzed by Western blot using an antibody mixture containing 
pm 142 and pm 143 antisera. Lysates from unfractionated cells infected with 
MCMV for 24 hours served as a positive control. B). The infected cell lysates 
from above were analyzed by Western blot using the phosphotyrosine 
phosphatase (PTP) antibody to assess nuclear contamination by the cytoplasmic 
fraction.
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kinetics experiment described previously pm 143 was not detected when cells were 
infected with an MOI of 2 for 3 hours, when the MOI was increased to 5 in this 
experiment, pm!43 was readily detected at 3 and 4 hours. Increasing the MOI likely 
increased the expression levels o f  the 143 protein, and therefore assisted in its detection. 
The pml43 protein also localized to both the nucleus and the cytoplasm at approximately 
equal amounts at 3 and 4 hours post infection (Fig. ISA). As a control to detect the 
degree of contamination o f the nuclear fraction with the cytoplasmic fraction, the 
phosphotyrosine phosphatase antibody was used to analyze these lysates. The 
phosphotyrosine phosphatase protein localizes specifically to the cytoplasm. Since the 
phosphotyrosine phosphatase protein was present almost exclusively in the cytoplasmic 
fraction, this confirms that minimal cytoplasmic contamination o f the nuclear fraction 
occurred (Fig. 15B).
In parallel to the immunofluorescence studies, we wanted to determine pm 142 
and pml43 localization at 24 hours post infection. Both pm!42 and pml43 were found 
in the nuclear and cytoplasmic fractions at 24 hours post infection (Fig. 16A) It appears 
that more pm l42 and pml43 protein was present in the cytoplasmic fraction than the 
nuclear fraction, since equal representative volumes of each sample were analyzed by 
Western blot. Also the control protein phosphotyrosine phosphatase localized 
predominately to the cytoplasm, suggesting that minimal cytoplasmic contamination of 
the nuclear fraction occurred (Fig. 16B).
In summary, cell fractionation studies have shown that both pm 142 and pm 143 
localized to the nucleus and the cytoplasm at 3, 4, and 24 hours post infection. With the 
immunofluorescence studies, it was shown that at 24 hours post infection pm 142 and
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pm 143 localized predominantly to the cytoplasm, with low levels o f  pm 142 and pm 143 
nuclear protein. Our next goal was to determine the ability o f pm l42 and/or pml43 to 
transactivate several MCMV promoters. Since pml42 and pml43 are early proteins, we 
will determine their ability to activate the expression o f the early el gene that is involved 
in viral DNA replication (Pari and Anders, 1993). We will also investigate the ability of 
pm 142 and pm 143 to activate the MCMV immediate early promoter.
A . MOCK WT MCMV
66 kD -
M S B T  « - 53 kD pm l43
45 kD -  _ 43 kD pm l42




m gm  112 kD PTP
97 kD -  _____
N C
FIG. 16. pml42 and pml43 localize to the nucleus and the cytoplasm at 24 hours 
post infection. A.) NIH 3T3 fibroblast cells were mock infected or infected with 
wild type (WT) MCMV at an MOI of 5 for 24 hours. The NE-Per Nuclear and 
Cytoplasmic Extraction Reagent (Pierce) was used as described in the Materials 
and Methods to separate the nuclear (N) and the cytoplasmic (C) fractions of the 
infected cells. The lysates were then analyzed by Western blot using an antibody 
mixture containing pm 142 and pm 143 antisera. B). Infected cell lysates from 
above were analyzed by Western blot using the phosphotyrosine phosphatase 
(PTP) antibody to assess nuclear contamination by the cytoplasmic fraction.
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Functional Characterization of the pm 14:2 and pml43 proteins
We propose that pm!42 and/or pml43 are transcrip tional transactivators. As 
previously stated, pm l42 and pml43 are members o f the LFS22 gene family, some o f 
which are transcriptional transactivators. Also, pm 142 and. pm 143 are homologous to the 
IRS 1/TRS 1 proteins o f HCMV (Rawlinson et al., 1996), amd are regulated similarly to 
IRS 1/TRS 1. IRS 1/TRS 1 are involved in the regulation o f genes active during viral DNA 
replication (Pari ayd Anders, 1993; Pari et al. 1993; Iskend«erian, 1996; Kerry et al.,
1996). According to the cell fractionation experiments and! immunofluorescence 
analysis, the pml42 and pml43 proteins also localize to th e  nucleus (Fig. 14A, 14B, 15A, 
16A). Therefore we next determined the transactivation capabilities of pm 142 and 
pm 143 collectively and individually.
These studies commenced immediately after the m il42 and m l43 transcripts were 
identified as immediate early RNAs, but prior to the analys-is o f their gene products.
Since the m l42 and m l43 transcripts were immediate early , we reasoned that their 
protein products are likely expressed at immediate early tinnes as well. The other 
immediate early proteins of MCMV (IE1, IE3, and IE2) a re  involved in the regulation of 
the MCMV major immediate early promoter and enhancer ■ (MIEPE). The MCMV IE I 
and IE2 proteins positively regulate the MIEPE, while IE3 represses expression from this 
promoter/enhancer (Koszinwoski et al., 1986; Messerle et a l . ,  1992; Cardin et al., 1995). 
Therefore, we began our analysis of ml42 and ml43 functLon by investigating the ability 
o f pml42 and pml43 to enhance activation o f the MIEPE Q el/ie3  promo ter/enhancer).
For these studies, the vector MCMV3CAT (M IEP-CAT) was kindly provided by 
Dr. Martin Messerle (Department of Virology, University o f  Ulm, Germany) (Messerle
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FIG. 17. Schematic representation of the promoter/enhancer regions used in 
transient assays. A. Schematic representation of the MCMV IE 
enhancer/promoter (M l22-123) used in the transient assays. Structural 
organization o f known consensus binding sites for cellular transcription factors, 
repeat elements, restriction enzyme sites and TATA box are shown (Dorsch- 
Hasler et al., 1985; Sanford and Bums, 1996). B. Sequences of the el 
enhancer/promoter (Ml 12-113) used in transient assays. Structural organization 
o f the predicted consensus binding sites for cellular transcription factors. 
Restriction enzyme sites are denoted.
et al., 1992). This vector contains the entire MCMV major IE enhancer and promoter 
(M122-123) upstream of the chloramphenicol acetyl transferase gene (CAT). This 
enhancer/promoter region (MCMV sequences 182851-184237) includes all of the known 
MIEPE transcription factor binding sites and repeat elements (Fig. 17A) The CAT gene 
serves as a reporter that allows the amount of transactivation to be determined by CAT 
assay.
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FIG. 18. Description of m l42/m l43 plasmids used in transient assays.
A. Structural organization o f the ml42-ml43 gene region. Location o f the 
promoter sequences (Pro) are depicted by black boxes and restriction enzyme 
sites are denoted (B; BsrG). Numbers refer to nucleotides within the MCMV 
genome. B. Map o f plasmid inserts containing ml42 and/or m 143 used in 
transient assays. C. Map of pCDNA3.1 vector (Invitrogen) that was used to 
express m l42 and/or m l43 proteins. Broken lines depict the location in which 
these genes were cloned (multiple cloning site).
Expression of pm 142 and pm 143 from the plasmid 142/143pCDNA3.1. To 
determine if the pml42 and pml43 proteins activate the MCMV MIEPE, a plasmid was 
generated to express the m l42 and m l43 genes collectively. The m l42 and ml43 genes, 
along with their native promoters, were cloned into the expression vector pCDNA3.1 
(Invitrogen) as described in the Materials and Methods. This construct includes MCMV 
sequences 198878-203538, and contains the entire m l42 and m l43 open reading frames 
with their native promoters and polyadenylation signal (Fig. 5, 6A.). The construct that 
contains both m l42 and ml43 was called 142/143pCDNA (Fig. 18B.). The pCDNA3.1 
vector contains the HCMV major immediate early promoter/enhancer (FIG 18C.), which 
appears to be necessary for optimal expression o f pml42 and pm 143 from these
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FIG. 19. Proteins pml42 and pmL43 are expressed from the plasmids 
142/143pCDNA, L42pCDNA and I43pCDNA. A. NIH 3T3 fibroblasts were 
transfected with 1, 3, 5, 7, or 10 pg of 142/143pCDNA. The cells were then 
harvested after 48 hours and analyzed by Western blot using a pmI42 and pm 143 
antibody mixture. B. NIH 3T3 fibroblast cells were transfected with 2, 3, 5, or 7 
pg o f 142pCDNA or 143pCDNA as indicated. Lysates from cells infected with 
wild type MCMV serve as a positive control. Cell lysates were harvested at 48 
hours and analyzed as described above. Asterisks denote low levels of protein 
expression
sequences, since a vector lacking the HCMV MIEPE did not express pml42 and pml43 
to detectable levels by Western blot analysis.
The 142/l43pCDNA vector was tested in transient assays to make sure that 
pm 142 and pm 143 proteins were expressed from this vector. NIH 3T3 fibroblast cells 
were transfected with 1, 3, 5, 7, and 10 pg of 142/143pCDNA. The pml42 and pml43 
proteins were not detected when 1, 3, or 5 pg o f 142/143pCDNA were transfected (FIG.
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19A.). However, the pm 142 and pm 143 proteins were detected when at least 7 pg of 
DNA was transfected, although the levels of protein were very low (Fig. 19 A.). These 
promoters may require other viral proteins for efficient activity. This could also be 
explained by expression of pm l42 and pm.143 from their native promoters, which may be 
very weak.
Activation o f the iel/ie3 enhancer/promoter by the pm!42 and pm!43 proteins. 
The vector 142/143pCDNA was tested in transient transfections to determine if  pm 142 
and/or pml43 transactivates the MCMV MIEPE. Various amounts o f 142/l43pCDNA 
were transfected into NIH 3T3 cells, along with 1 pg o f the plasmid MIEP-CAT as 
described in figure 20. Following transient transfection o f the given constructs, cell 
lysates were analyzed by chloramphenicol acetyl transferase assay as described in the 
Materials and Methods. When 1.0 pg of the vector 142/143pCDNA was transfected with 
the MIEP-CAT construct, transactivation of the MCMV MIEPE was minimal (Fig. 20). 
However when 2.0 or 3.0 pg of 142/l43pCDNA was used, the transactivation levels rise 
to at least 3 fold above basal levels. Although low levels o f pm 142 and pm 143 were 
expressed under these conditions (Fig. 19A), promoter activity was still increased. 
Therefore the m l42 and/or ml 43 gene products enhance activation o f the MCMV 
MIEPE. We believe that increasing the concentration of 142/143pCDNA increased the 
level of pm l42 and pml43 expression, thus allowing optimal levels o f transactivation to 
be obtained. Initially we were not surprised by these results, since it was known that 
immediate early gene products activate the MIEP. However, when it was subsequently 
determined that pm 142 and pm 143 are early proteins, the interpretation o f these results
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FIG. 20. Activation o f the MCMV immediate early promoter/enhancer (MIEP) 
by IE proteins pml42/pml43. A total of 1.0 pg o f reporter plasmid 
MCMV3CAT (MIEPCAT) was transfected into NIH 3T3 fibroblasts with the 
empty vector pCDNA3.1 (lane 1), or with the plasmid 142/143pCDNA at 1.0 pg 
(lane 2), 2.0 pg (lane 3), or 3.0 pg (lane 4). The empty vector pCDNA3.1 
(Invitrogen) was used to maintain a constant amount o f plasmid DNA per 
transfection. Cell lysates were harvested 48 hours post transfection and analyzed 
as described in the Materials and Methods. The transfections were done in 
duplicate and each experiment was repeated three times. Error bars represent 
standard deviations.
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142pCDNA 0 3.0 0 1.5 0 0
143pCDNA 0 0 3.0 1.5 0 0
142/143pCDNA 0 0 0 0 3.0 0
p IE lll 0 0 0 0 0 1.0
pCDNA3.1 4.0 1.0 1.0 1.0 1.0 3.0
FIG. 21. Both pml42 and pml43 are required for activation o f the MCMV 
immediate early promoter/enhancer (MIEP). A total of 1.0 pg of the reporter 
plasmid MCMV3CAT (MIEPCAT) was transfected into NIH 3T3 fibroblasts 
with the empty vector pCDNA3.1 (lane 1), or with the plasmids !42pCDNA (lane 
2), !43pCDNA (lane 3), 142pCDNA and 143pCDNA (lane 4), 142/l43pCDNA 
(lane 5), or pIEl 11 (lane 6). The empty vector pCDNA3.1 (Invitrogen) was used 
to maintain a constant amount of plasmid DNA per transfection. The numbers 
denote the amount of plasmid DNA transfected in pg. Cell lysates were 
harvested 48 hours post transfection and analyzed as described in the Materials 
and Methods. The transfections were done in duplicate and each experiment was 
repeated three times. Error bars represent standard deviations.
Expression of pml42 and pml43 from the plasmid 142pCDNA and 143pCDNA 
Since 142/143pCDNA expresses both pml42 and pml43, we were not sure which 
protein functioned to enhance transcriptional transactivation. Therefore, we wanted to 
determined if pml42, pmI43 or both have the ability to enhance transactivation.
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Expression plasmids containing m l42 and ml43 alone were cloned into pCDNA3.1 as 
described in the Materials and Methods. The plasmid 142pCDNA contains the entire 
m l42 sequence (MCMV sequences 199412-200517) but not the m l42 promoter. The 
plasmid 143pCDNA contains the entire ml43 sequence, but not the m l43 promoter 
(MCMV sequences 202602-202626) (Fig. 18B). These plasmids were also tested in 
transient assays to determine if pm 142 and pm 143 were expressed from their respective 
expression vectors. NIH 3T3 cells were transfected with 2, 3, 5 and 7 pg o f 142pCDNA 
or 143pCDNA, and cell lysates were analyzed by Western blot analysis using a pml42 
and pml43 antibody mixture. Unlike 142/143pCDNA, the levels o f protein expressed 
from 142pCDNA and pml43pCDNA were very high. With as low as 2 pg of 
142pCDNA and 143pCDNA, the pm l42 and pml43 proteins, respectively, were clearly 
detectable (Fig. 19 A). High levels o f protein expression are likely due to the presence of 
the HCMV MIEP that is located immediately upstream o f  the ml 42 and m l 43 sequence.
Both pm 142 and pm!43 are required for transactivation of the MCMV MIEPE.
In order to determine if pml42, pm l43 or both has the ability to enhance transactivation 
of the MIEPE, the plasmids containing m l42 or ml43 alone (called 142pCDNA or 
143pCDNA, respectively) were tested in transient transfection assays along with MIEP- 
CAT. The positive control plasmid expressing both IE1 and IE3 transactivates this 
promoter 10 fold above basal levels. However, proteins expressed from neither 
142pCDNA nor 143pCDNA transactivated the MIEPE alone (Fig. 21). When the 
construct 142/143pCDNA was transfected with the MIEP-CAT construct, transactivation 
of 3-4 fold above basal levels was obtained. Therefore both pml42 and pml43 are
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necessary for transactivation o f the MIEPE to occur. To our surprise, when both 
142pCDNA and 143pCDNA were transfected together, transactivation of the MIEPE 
above basal levels was not achieved. This could be due to the phenomenon o f 
squelching, since the levels o f protein expressed from 142pCDNA and 143pCDNA under 
these conditions were very high compared to proteins expressed from 142/143pCDNA 
(Fig. 22). It is also possible that a splice variant may be expressed from 142/143pCDNA. 
There is some evidence that splicing o f the m l 42 transcript may be occurring since the 
size o f the m l42 transcript changes from 1.8 kb to 1.6 kb as time progresses (Fig. 8).
Also an alternate transcript may be expressed from 142/143pCDNA (ml42b, ml42c) that 
is not expressed from 142pCDNA or 143pCDNA, and that protein product may act as the 
transcriptional transactivator (Fig. 6A).
53 k D —► a|e pml43
43 kD *  pm!42
142pCDNA 0 3.0 0 1.5 0 0
143pCDNA 0 0 3.0 1.5 0 0
142/143pCDNA 0 0 0 0 3.0 3.0
pIE H l 0 0 0 0 0 0
pCDNA3.I 4.0 1.0 1.0 1.0 1.0 1.0
FIG. 22. Elevated expression o f pm 142 and pm 143 may have caused squelching 
to occur in the MCMV MIEP promoter analysis. NIH 3T3 cells were transfected 
with the indicated plasmids. The numbers refer to pg of DNA. Cell lysates were 
harvested 48 hours post transfection and analyzed by Western blot analysis using 
a pm l42 and pml43 antibody mixture. Asterisks denote location o f proteins. 
Last lane includes a darker exposure.
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FIG. 23. The m l 42/m 143 gene products enhance expression from the HCMV 
MIEP. NIH3T3 fibroblasts were transfected with an HCMV-MIEP driven 
MCMV M140 expression vector (lanes 1 and 3) or cotransfected with the same 
construct in addition to the ml42/143 expression vector (lane 2). Cells were 
mock-infected (lane 1 and 2) or superinfected with a MCMV triple deletion 
mutant (A139-14l)(lane 3). Wild type (WT) infected lysates serve as a positive 
control (lane 4). Transfection, superinfection and Western blot analyses were 
conducted as described in the Materials and Methods.
m l42 and m l43 gene products can transactivate the HCMV MIEPE. An alternate 
approach was used to test the ability of the pml42 and pml43 to activate the HCMV 
MIEPE. It has previously been shown that the HCMV MIEPE can substitute for the 
MCMV MIEP in the context of an MCMV infection (Angulo et al., 1998; Grzimek et al., 
1999). In our laboratory we had a construct containing the MCMV M140 gene under the 
control o f the HCMV MIEPE. We reasoned that if pm l42 and pml43 are able to activate 
the MCMV MIEP, they should also be able to transactivate the HCMV MIEP.
Therefore, in the presence o f pm 142 and pm 143, M140 protein expression should be
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increased. We cotransfected a M140 expression plasmid with the 142/143pCDNA 
plasmid into NIH 3T3 cells. We then analyzed the lysates for levels o f M140 protein by 
Western blot analysis using a M l 40 antibody. Our results show that the levels of M l 40 
were increased when pm 142 and pml43 were present compared to M140 alone (Fig. 23). 
These levels were even higher than those found in cells superinfected with the A139-141 
mutant virus that contains the full repertoire of IE proteins. Therefore, pm 142 and/or 
pm 143 are able to transactivate the HCMV MIEPE. These results were not surprising 
since it was previously shown that pmI42 and pm 143 transactivated the MCMV MIEPE. 
The HCMV and MCMV MIEPE have some sequence homology and therefore pm 142 
and pm 143 proteins may function via similar sequences within both the MCMV and 
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FIG. 24. Structural organization of the MCMV major IE gene loci (M122-123). 
Map o f MCMV major immediate early gene region and useful restriction enzyme 
sites. The promo ter/enhancer region is denoted by a black box. Also included 
are IE transcripts and plasmids used in transient assays (Messerle et al., 1992). 
The dotted line denotes deleted sequences and restriction enzyme abbreviations 
are as follows: B, BamHl; E, EcoRl; A, Aval; M, M scl; Hp, Hpal; and H,
Hind 111.
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Lack o f cooperativity between IE1/IE3 and pml42/pm!43 in the activation of the 
MCMV MIEP (M 122-123). In HCMV and MCMV, it has been shown that the 
immediate early proteins can act cooperatively in the activation of some promoters. We 
wanted to determine if  pmI42 and pml43 might cooperate with the MCMV IE I protein 
in transactivating the MIEP. Therefore, in the next study we used a plasmid that 
expresses both IE1 and IE3 proteins (pLE 111). This vector was kindly provided by Dr. 
Martin Messerle (Messerle et al., 1992) and is depicted in figure 24. The vector 
142/143pCDNA was cotransfected with the MIEP-CAT construct and the plasmid 
expressing both LEI and IE3 (pIEl 11). It has previously been shown that 1 pg of the 
IE1/IE3 expressing plasmid (pIEl 11) transactivates the MIEPE to very high levels. The 
high levels of transactivation can be attributed to IE1, which positively regulates the 
MIEPE (Kosinowski, 1986). Therefore, in our studies we reduced the amount of pIEl 11 
to 0.25 pg, since IE1 is such a potent transactivator o f the MIEPE. We then titrated in 
increasing amounts of 142/143pCDNA. We found that 0.25 pg of IE1/IE3 alone 
transactivated the MIEPE to about 1.6 fold above basal levels (Fig. 25). When 
142/143pCDNA was added, the levels of transactivation increased in a dose responsive 
manner. With 2.0 pg o f !42/l43pCDNA, transactivation by IE1 and IE3 doubled to 
almost 4 fold above basal levels, and with 3 pg of 142/143pCDNA activation of 5 fold by 
IE1/IE3 was found. The levels o f transactivation by IE1/IE3 and pml42/pml43 were 
additive, and no cooperativity was observed. These results were not surprising since the 
other MCMV immediate early proteins exhibit noncooperative effects on the MIEPE as 
well. For example, IE1 alone transactivates the MIEP, while IE3 alone represses the








p I E lll 0 0.25 0.25 0.25 0.25 0
142/143pCDNA 0 0 1.0 2.0 3.0 3.0
pCDNA3.1 4.0 3.75 2.75 1.75 0.75 1.0
FIG. 25. Additive effects between the proteins pml42/pml43 and IE1/3 in 
activating the MCMV MIEP. A total of 1.0 jag o f the reporter plasmid 
MCMV3CAT (MIEPCAT) was transfected into NTH 3T3 fibroblasts with the 
empty vector pCDNA3.1 (lane 1) or with plasmids pIEl 11 (IE1 and IE3) and/or 
m!42/143pCDNA. The amount o f pIEl 11 DNA was kept constant at 0.25 pg per 
sample (lanes 2-5) and !42/143pCDNA was titrated in at 1.0 pg (lane 3), 2.0 pg 
(lane 4), 3.0 pg (lane 5) or 3.0 pg (lane 6). The empty pCDNA3.1 vector was 
used to maintain a constant amount of plasmid DNA per transfection. Cell lysates 
were harvested 48 hours post transfection and analyzed as described in the 
Materials and Methods. The transfections were done in duplicate and each 
experiment was repeated three times. Error bars represent standard deviations.
MIEP. When IE1 and IE3 are combined, their effects on the MIEP are additive 
(Messerle et al., 1992).
In this experiment the level o f transactivation o f the MIEPE by IE1/IE3 and 
m l42/m l43 were additive. Since iel and ie3 are under the control of their native 
promoter, the MIEPE, in the iel/ie3 expression vector (pIEl 11), it is possible that the
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additive levels o f  transactivation by m 142/m 143 and IE1/IE3 result from an increase in 
the expression of IE1. The proteins m l42 and ml43 may cause an increase in IE1 
expression from pIEl 11, and IE1 could then transactivate the MIEP-CAT plasmid 
resulting in an increase in CAT expression. In order to determine if  m l42/m l43 and 
IE/IE3 contribute to the activation o f the MIEP-CAT independently in an additive 
manner or if  ml42/ml43 are increasing LEI expression under these conditions, Western 
blot analyses looking at IE 1 levels would have to be done in parallel with the 
transactivation studies.
pm!42 and pm!43 fail to activate the early el (Ml 12-113) promoter. Since 
pm 142 and pm 143 are early proteins, they likely transactivate genes that are expressed at 
early times. Furthermore, pm l42 and pml43 have homology to IRS1-TRS1 of HCMV. 
IRS1/TRS1 have been shown to activate early genes involved in viral DNA replication. 
So, we wanted to determine if  pm l42 and pml43 are able to transactivate early genes 
involved in DNA replication. In these studies we used the early el promoter (Ml 12-113) 
(Fig. 17B). The e l gene (Ml 12-113) encodes nuclear localized proteins that are 
homologous to HCMV UL112-113 gene products required for HCMV ori-Lyt dependent 
viral DNA replication. The plasmid e 1-CAT was kindly provided by Dr. Martin 
Messerle (Messerle et al., 1992) and includes MCMV sequences 160352-162095 
upstream of the CAT gene (Fig. 17B). This promoter contains several predicted 
consensus binding sites for the cellular transcription factors GM-CSF, AP-1, CRE and 
SP1. When NIH 3T3 cells were transiently transfected with 1.0 pg o f the e 1-CAT 
construct and 1.0 pg of 142/143pCDNA, there was no transactivation (Fig. 26). When










142/143pCDNA 0 1.0 2.0 3.0 0
p I E lll 0 0 0 0 1.0
pCDNA3.1 4.0 3.0 2.0 1.0 3.0
FIG. 26. Failure o f the proteins pm 142 and pm 143 to activate the early el 
promoter. A total o f 1.0 jag o f the reporter plasmid el CAT was transfected into 
NIH 3T3 fibroblasts with the empty vector pCDNA3.1 (lane 1), or with the 
plasmid 142/143pCDNA at 1.0 pg (lane 2), 2.0 pg (lane 3), or 3.0 pg (lane 4). As 
a positive control the plasmid pIEl 11 (IE1 and IE3) was used (lane 5). The 
empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant amount of 
plasmid DNA per transfection. Cell lysates were harvested 48 hours post 
transfection and analyzed as described in the Materials and Methods. The 
transfections were done in duplicate and each experiment was repeated three 
times. Error bars represent standard deviations.
142/143pCDNA was increased to 2.0 pg and 3.0 pg, transactivation still did not take 
place. However, the IE1/IE3 proteins were potent transactivators o f this promoter. 
Therefore, pm 142 and/or pm 143 do not transactivate the e l promoter alone.
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pm 142 and pm 143 proteins cooperate with IE1 and IE3 to transactivate the el 
promoter (M l 12-113). Since IE1 and IE3 act synergistically to transactivate the el 
promoter (Messerle et ah, 1992), we wanted to determine if pml42 and/or pml43 might 
enhance this phenomenon. In order to do this, we transfected NTH 3T3 cells with 1.0 pg 
o f el-CAT and 0.25 pg o f the iel/ie3 plasmid (pIEl 11), along with various amounts of 
142/143pCDNA. We used the concentration o f 0.25 pg of pIEl 11 since 1.0 pg of 
pIEl 11 transactivated this promoter to very high levels (80% acetylation). Although 
proteins expressed from 142/143pCDNA did not transactivate el-CAT in the absence of 
other viral proteins, pm l42 and/or pml43 cooperated with IE1/IE3 in transactivating the 
e l promoter (Fig. 27). When el-CAT was transfected along with 0.25 pg of the IE1/IE3 
expression plasmid (pIEl 11), activation of about 30 fold above basal levels was 
achieved. When 1.0 pg o f the plasmid 142/143pCDNA was added, transactivation 
increased to about 40 fold above basal levels. The fold activation continued to increase 
as more 142/143pCDNA was added. Therefore, this response was dose dependent. 
Activation as high as 80 fold above basal levels was achieved when 3 pg of 
142/143pCDNA was added. Therefore pm!42 and/or pml43 cooperate with IE1/IE3 in 
activating the e l promoter. We were very excited about these findings since this is the 
first documentation that other MCMV viral proteins assist in IE1/IE3 mediated 
transactivation of the e l promoter or any other promoter.
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5 60
p IE lll 0 0.25 0.25 0.25 0.25
142/143pCDNA 0 0 1.0 2.0 3.0
pCDNA 3.1 4.0 3.75 2.75 1.75 0.75
FIG. 27. Cooperation between the proteins pm l42/pm l43 and IE1/3 in activating 
the early e l promoter. A total of 1.0 pg of the reporter plasmid elCA T was 
transfected into NIH 3T3 fibroblasts with the empty vector pCDNA3.1 (lane 1) or 
with plasmids pIEl 11 (IE1 and IE3) and ml42/143pCDNA. The amount of 
pIEl 11 DNA was kept constant at 0.25 pg per sample (lane 2-5) and 
142/143pCDNA was titrated in at 1 pg (lane 3), 2 pg (lane 4) or 3 pg (lane 5).
The empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant 
amount o f plasmid DNA per transfection. Experiments were conducted as 
described in the Methods. The transfections were done in duplicate and each 
experiment was repeated three times. Error bars represent standard deviations.














p I E l l l 0 0.25 0.25 0.25 0.25 0.25
142pCDNA 0 0 3.0 0 1.5 0
143pCDNA 0 0 0 3.0 1.5 0
142/143pCDNA 0 0 0 0 0 3.0
pCDNA3.1 4.0 3.75 0.75 0.75 0.75 0.75
FIG . 28. Both pm 142 and pm 143 are required for maximal cooperation with 
IE1/IE3 proteins in the activation of the early e l promoter. A total o f 1.0 pg of 
the reporter plasmid elCAT was transfected into NIH 3T3 fibroblasts with the 
empty vector pCDNA3.1 (lane 1) or with plasmids pIEl 11 (IE1 and IE3) (lanes 2- 
6), 142pCDNA (lane 3), 143pCDNA (lane 4), 142pCDNA and 143pCDNA (lane 
5) or ml42/143pCDNA (lane 6). The numbers denote the amount o f DNA added 
in pg. The empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant 
amount o f plasmid DNA per transfection. Experiments were conducted as 
described in the Methods. The transfections were done in duplicate and each 
experiment was repeated three times. Error bars represent standard deviations.
Both pm!42 and pm!43 are required for the cooperative activity with IE1 and IE3 
in the transactivation of the e 1 promoter. We went on to determine if pm 142, pm 143 or 
both might cooperate with IE 1 and IE3 in activating the e I promoter. In order to do this 
we transfected the el-CAT construct and pIEl 11 along with 142pCDNA, !43pCDNA, or 
both 142pCDNA and !43pCDNA as shown in figure 28. Unfortunately we do not have
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data from cells transfected with el-CAT and 142pCDNA or 143pCDNA alone. 
Therefore, we can only speculate that proteins expressed from 142pCDNA and 
143pCDNA fail to transactivate the e l  promoter, like those expressed from 
142/143pCDNA. We found that in the presence of pml42 alone, the activity mediated by 
LEI and IE3 doubles. The protein pml43 however, does not assist IE1/IE3 in the 
activation o f  the e l promoter. When I42pCDNA and I43pCDNA were transfected 
together, transactivation by IE1/IE3 was increased but to levels that were not significant. 
However, pm l42 and pm!43 expressed from 142/143pCDNA was found to cooperate 
with IE1 and IE3, allowing transactivation o f the MIEP to reach 140 fold above basal 
levels. Therefore the co-expression o f the plasmids 142pCDNA and 143pCDNA did not 
restore cooperation with IE1 and IE3 to the levels seen with 142/143pCDNA. As 
mentioned previously, this can be explained by squelching since there is more pm 142 and 
pml43 expressed from 142pCDNA andl43pCDNA than from 142/143pCDNA under 
these conditions (Fig. 29). Also, since the m l42 and ml43 proteins are overexpressed 
from 142pCDNA and 143pCDNA, there could be improper localization of the ml42 and 
m l43 proteins. Also, an alternate protein may be made from the 142/143pCDNA vector, 
which may contribute to the activation o f this promoter. From these data we can 
conclude that both pm 142 and pm 143 act cooperatively with the immediate early proteins 
IE1 and IE3, since the proteins expressed from 142/143pCDNA dramatically increased 
the activation seen with IE1 and IE3.
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p I E lll 0 0.25 0.25 0.25 0.25 0.25
142pCDNA 0 0 3.0 0 1.5 0
143pCDNA 0 0 0 3.0 1.5 0
142/143pCDNA 0 0 0 0 0 3.0
pCDNA3.1 4.0 3.75 0.75 0.75 0.75 0.75
FIG. 29. Elevated expression o f pm 142 and pm 143 may have caused squelching 
to occur in the el promoter analysis. NIH 3T3 cells were transfected with the 
indicated plasmids. The numbers refer to pg o f DNA. Cell lysates were 
harvested 48 hours post transfection and analyzed by Western blot analysis using 
a pml42 and pml43 antibody mixture. Asterisks denote low levels o f protein 
expression.
Summary of transactivation results. Proteins pm 142 and pm 143 were able to 
transactivate the MCMV MIEPE in a dose dependent manner to at least 3 fold above 
basal levels, and both proteins were necessary for transactivation to occur. These 
proteins were also able to transactivate the HCMV MIEPE. However, pml42 and pm 143 
proteins exhibited noncooperative effects with IE1/IE3 in the activation of the MCMV 
MIEPE. Collectively pml42 and pml43 failed to activate the early el promoter. 
However when in combination with IE1 and IE3, cooperative activity by pm!42 and 
pm 143 was observed in the activation of the el promoter. Although pm 142 alone 
assisted IE1 and IE3 to some degree, both pm 142 and pm 143 were required for optimal 
activity.




Kinetics of ml42 and ml43 RNA Expression
MCMV genes mI42 and mL43 are required for replication in NIH 3T3 fibroblast 
cells. Therefore, these genes are essential and play a very important role in the biology of 
MCMV. The gene m l42 includes MCMV sequences 199444-200748, and the gene 
ml43 includes MCMV sequences 200923-202593. The m l42 transcript is 1.8 kb in size 
and the 5’ end of the transcript has been mapped to MCMV sequences 200847 or 200848. 
The ml43 transcript is 3.8 kb in size and the 5’ end of the transcript starts at MCMV 
sequences 202694 or 202686 (Fig. 5, 6). Both m l42 and m l43 are transcribed at 
immediate early times, and their steady state levels increase and remain abundant at early 
and late times. In addition to the m l42 and m l43 transcripts, several unexpected 
transcripts were expressed from the ml42-ml43 gene region at early and late times.
These unexpected transcripts are 1.6 kb and 2.2 kb in size (Fig. 8). The 1.6 kb transcript 
may result from splicing o f the 1.8 kb m l42 transcript. However, nuclease mapping 
studies would have to be done to confirm this. The 1.6 kb band could also be an early 
transcript containing another potential ORF within m l42, designated ml42b. 
Alternatively, the 1.6 kb transcript may result from a shorter poly (A) tail of the 1.8 kb 
transcript. A similar type o f regulation has been observed for the HCMV iel transcript 
(Stamminger, 1991). The 2.2 kb transcript most likely contains ORF ml42c, however 
the mapping of the 5’ end o f the 2.2 kb transcript has not yet been done (Fig. 6). 
Therefore, more extensive mapping is needed in this region to confirm the origin of the 
1.6 kb and 2.2 kb RNAs and to determine if splicing occurs in this region.
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The expression pattern o f m l42 and ml43 is different from the expression o f the 
other MCMV immediate early genes. The immediate early genes iel and ie3 are 
expressed at abundant levels at IE times. However, they are not expressed at early and 
late times o f viral infection. The expression kinetics o f  m l 42 and m l 43 RNAs are quite 
similar to HCMV immediate early genes LRS1/TRS1, which are required for the 
activation of early genes involved in HCMV viral replication. IRS 1 and TRS1 transcripts 
are present at immediate early, early and late times. Interestingly, m l42 and m l43 also 
have homology to IRSl/TR Sl. This suggests that, unlike iel and ie3, ml42 and m l43 are 
similar to IRSl/TRSl in that they likely have important functions at early and late times 
of viral infection. In our studies, we have shown that m l42 and ml43 do in fact have 
functional similarity to IRSl/TRSl, by cooperating with IE1/IE3 in the activation o f an 
early gene.
Characterization of pml42 and pml43
The m l42 and m i43 protein products (designated pm 142 and pm 143, 
respectively) were characterized according to size, kinetics and location within an 
MCMV infected cell. According to the DNA sequence, the expected size for the m l42 
protein product was 48 kD, and the expected size for the m l43 protein product was 64 
kD. However these proteins proved to be smaller than expected. The m l42 protein 
corresponds to a 43 kD protein product and the ml43 protein corresponds to a 53 kD 
protein product (Fig. 10). These protein products may be smaller than expected due to 
proteolytic processing o f the proteins. However, since there was no variation in the sizes 
of the m l42 and ml43 proteins as the infection progressed, this is unlikely (Fig. 12).
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Splicing of the m!42 transcript could also be taking place since the m l42 transcript shifts 
from 1.8 kb to 1.6 kb as the viral infection progresses, possibly resulting in a shorter 
ORF. There is also precedence for proteins with a high proportion of basic or charged 
amino acids to migrate faster or slower than their actual molecular weight on a 
polyacrylamide gel (Takano et al., 1988). Since both pml42 and pml43 have a high 
content o f charged residues, they could be running faster on the polyacrylamide gel. 
Because the sizes o f pm 142 and pm 143 are smaller than expected, it is likely that no 
major posttranslational processing like phosphorylation or glycosylation is taking place 
although m l43 has two potential N-glycosylation sites.
The proteins pml42 and pml43 were expressed differently from the MCMV IE1 
and IE3 proteins. The LEI and IE3 proteins are present by 2 hours post infection, and 
then gradually decrease. These proteins (IE1 and IE3) are not detectable at early and late 
times. The pm l42 and pml43 proteins, however, were detectable at 3 hours post 
infection and increased as the viral infection progressed (Fig. 12). Interestingly, the 
kinetics o f pm!42 and pm!43 expression (like their RNA) was similar to IRS 1/TRS1. 
IRSl/TRSl are expressed at 2 hours post infection and remain throughout the entire 
HCMV replication cycle at relatively high levels (Romanowski and Shenk, 1997). 
However unlike IRSl/TRSl, pm 142 and pm 143 are not expressed to detectable levels 
under conditions in which only the immediate early proteins are expressed. Therefore, 
the m l42 and ml43 protein products cannot be designated as immediate early proteins. 
However, since Western blot analyses are not very sensitive assays, it is possible that 
pm 142 and pm 143 are present at IE times, but not to levels that are not detectable by this
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method. To address this, we could perform 35S labeling o f infected cells followed by 
immunoprecipitations using pm 142 and pm 143 antisera.
It was surprising to find that the m!42 and ml43 genes, which are immediate 
early genes, expressed their protein products at early times (Fig. 13). Since this occurs, 
there is likely control o f ml42 and ml43 at the level of translation. This control can be 
mediated by sequences at the 5’ untranslated region (UTR) or the 3’ UTR o f the m l42 
and ml43 transcript. For example, the HCMV UL99 gene is regulated by leader 
sequences (Kerry et al., 1997), having secondary structure that interferes with the 
scanning of the ribosomal preinitiation complex (Gray and Wickens, 1998). Other CMV 
genes can be regulated at the level of translation by short ORFs. The CMV UL4 gene 
contains a 22 codon upstream ORF, whose protein product represses downstream 
translation by blocking translational termination at its own stop codon, thus causing 
ribosomes to stall on the mRNA (Alderete et al., 1999).
It is possible that m l42 and ml43 are regulated by secondary structure at the 5 ’ 
UTR or short ORFs. The former is not likely because algorithmic analyses predict the 5’ 
UTR o f m l 42 and m l 43 to be moderately stable, and therefore secondary structure at the 
5’UTR should not inhibit migration of the ribosomal subunit. The stem loop structure of 
the m l42 5 ’ UTR was calculated to have an optimal standard free energy value (AG) of 
about -32 Kcal/mole. The stem loop structure o f the ml43 5’ UTR was calculated to 
have an optimal standard free energy value (AG) o f about —30 Kcal/mol. Stem loop 
structures that inhibit translation usually have an optimal standard free energy value of
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-50 Kcal/mol or lower (Kozak, 1989). However, this does not rule out the involvement 
o f other cellular or viral proteins that may bind to sequences within the 5’ UTR and 
hinder the progression of the preinitiation complex.
It is possible that translation o f m l42 and ml43 mRNA is regulated by a short 
open reading frames contained in the m l42 5 ’ UTR (Fig. 6). The protein product o f this 
ORF could be involved in the repression o f m l42 or ml43 protein expression. However, 
analysis o f the 5’ end revealed no ORF in this region. It is also possible that sequences at 
the 3 ’ UTR o f m!42 and ml43 can regulate translation by changing poly (A) tail length 
or by making contacts with the proteins involved in translational initiation (Gray and 
Wickens, 1998).
Since the m l42 and m l43 proteins were expressed during early times, they likely 
have important functions during this time in the viral replication cycle. Therefore, these 
genes could be involved in 1) viral pathogenesis or host immune evasion, 2) viral DNA 
replication or the regulation o f genes involved in viral DNA replication or 3) the 
regulation o f the major immediate early promoter and enhancer (MIEPE) by functioning 
similarly to the virion tegument proteins that have transactivating activity. We 
investigated the role pml42 and pm l43 play in the regulation of the MIEPE and the 
regulation of an early gene involved in viral DNA replication. Our results show that 
pm 142 and pm 142 regulate the MIEPE and the promoter o f at least one early gene 
involved in MCMV DNA replication.
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Intracellular Localization of pml42 and pml43
Most viral regulatory proteins are nuclear proteins that bind promoter/enhancer 
sequences or interact with cellular transcription factors. However, viral proteins located 
outside the nucleus can also regulate gene expression. For example, the UL37 protein is 
an integral membrane glycoprotein that traffics through the endoplasmic reticulum and 
Golgi apparatus. It is believed that UL37 protein product regulates viral gene expression 
via cell signaling (Zhang et al., 1996). However recent studies show that the acidic 
domain of UL37 plays a key role in transactivating viral promoters (Colberg-Poley et al., 
1998). Some investigators speculate that the acidic domain of membrane bound UL37 
may be released by proteolytic cleavage, translocate to the nucleus, and regulate gene 
expression in the nucleus (Colberg-Poley et al., 1998). Other viral regulatory proteins 
have been shown to shuttle between the nucleus and the cytoplasm, and perform different 
functions depending on their location. For example, the Tax protein of human T-cell 
leukemia virus type I shuttles between the nucleus and the cytoplasm (Burton et al., 
2000). While in the nucleus, Tax activates the promoters of viral and cellular genes. 
While in the cytoplasm, Tax indirectly regulates NFkappaB. Tax does this by interacting 
with the cytoplasmic inhibitor o f NFkappaB, thus allowing NFkappaB to translocate to 
the nucleus to regulate gene expression (Li and Gaynor, 1999). So although most 
proteins involved in gene regulation are nuclear proteins, we cannot assume that proteins 
that localize to the cytoplasm are not involved in the regulation of gene expression.
The cell fractionation studies have shown that both pm 142 and pm 143 localized 
to the nucleus and cytoplasm at 3, 4, and 24 hours post infection (Fig. 14A, 16A). In the 
immunofluorescence studies m l42 and m i43 localized predominantly to the cytoplasm at
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24 hours post infection, with low levels o f pml42 and pm 143 nuclear protein (Fig. 14A, 
14B). The difference in the immunofluorescence and cell fractionation results can be 
explained by the inherent differences between these two assays. In the cell fractionation 
experiments, the cell lysates were analyzed by Western blot under denaturing conditions, 
disrupting any protein-protein interactions. In the immunofluorescence studies, the cells 
were fixed in paraformaldehyde. Although this fixative preserves the architecture of the 
cell, it may cross-link amino groups on adjacent molecules stabilizing protein-protein and 
protein-nucleic acid interactions. If these interactions are taking place in the cell, it is 
possible that the antigenic epitopes of pm!42 and pm l43 may be masked. It is also 
possible that pm l42 and pm 143 are not present in the nucleus at a density that is 
detectable in this assay, or nuclear shuttling may be involved.
In the cell fractionation assays, it also appeared that pm 142 and pm 142 were 
present in both the nucleus and the cytoplasm at relatively similar amounts (Fig. 15A, 
16A). In the immunofluorescence assays however, most o f the pm 142 and pm 143 
appeared to localize to the cytoplasm (Fig. 14A, 14B). The nuclear and cytoplasmic 
fractions from the cell fractionation experiments were analyzed by Western blot. Since 
the Western blot method has a narrow quantitative range, we cannot assume that pm 142 
and pm 143 localize to the cytoplasm and the nucleus at equal amounts in an infected cell. 
In order to determine the relative amount of pml42 or pml43 in the nucleus and the 
cytoplasm, the cell fractionation experiments can be done using lysates from radiolabeled 
MCMV infected cells, followed by immunoprecipitation of the nuclear and cytoplasmic 
fractions with pm l42 or pml43 antisera. The immunoprecipitated samples then can be 
run on an acrylamide gel under denaturing conditions, the gel dried, and analyzed on a
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phosphorimager to quantitate the amount o f pm l42 or pml43 in the nuclear versus 
cytoplasmic fraction. These results would also indicate if pml42 and pml43 associate 
with other cellular or viral proteins while in the nucleus or the cytoplasm. It is also 
possible that pm l42 and pml43 may associate with each other.
MCMV US22 family members located adjacent to ml42 and m!43 in the MCMV 
genome form protein-protein interactions (Karabekian, unpublished data). It is likely that 
pm l42 and pml43 also associate, and therefore co-localize in a MCMV infected cell.
The pm 142 and pm 143 proteins are expressed similarly, localize to the same cellular 
compartments, and are both needed to enhance expression of several MCMV genes. In 
order to determine if  pm 142 and pm 143 associate with each other, immunoprecipitation 
experiments can be done on MCMV infected cells using pml42 or pml43 antisera. The 
immunoprecipitated samples then can be analyzed by Western blot using pm 142 and 
pm 143 antisera. Also, immunofluorecence studies can be done using confocal laser 
scanning microscopy to determine if these proteins co-localize. However, both pm 142 
and pm 143 antisera were generated in rabbits. Therefore if in the colocalization studies 
we use our pm 142 and pm 143 antisera as the primary antibody, followed by anti-rabbit 
secondary antibodies, pm 142 will not be distinguished from pm 143. Antisera against 
pm 142 or pm 143 must be generated in another animal like the mouse. This will allow a 
goat anti-mouse secondary antibody conjugated to a fluorescent molecule like Texas red 
to be used to localize pml42, while a goat anti-rabbit secondary antibody conjugated to 
FITC can be used to localize pm 143. Alternatively, either pm 142 or pm 143 antisera can 
be directly conjugated to a fluorescent molecule like Texas red. This will enable the
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pm 142 and pm 143 proteins to be distinguished by the confocal microscope since FITC 
and Texas red fluoresce at different wavelengths of light.
As stated previously, pml42 and pml43 were present in the nucleus and 
cytoplasm at early times (3 and 4 hours post infection). Both pml42 and pml43 were 
also present in the nucleus and cytoplasm at late times (24 hours post infection). 
Interestingly, HCMV IRS1 and TRS1 are present in the nucleus and the cytoplasm at 
immediate early and early times o f viral infection, however they localize predominantly 
to the cytoplasm at late times of viral infection (Romanowski and Shenk, 1997). During 
a viral infection, HCMV IRS 1 and TRS1 are packaged in the virion and transactivate the 
HCMV MIEPE following viral entry into the host cell. These proteins are also involved 
in the regulation o f the early replication fork proteins. Since pml42 and pml43 have 
homology to IRSl/TRSl and localize to the nucleus, we went on to determine the 
transactivating capability of these proteins by testing their ability to transactivate the 
MIEP and an early promoter involved in viral DNA replication.
Transactivation of the Major Immediate 
Early Promoter and Enhancer by pml42 and pml43
The pm 142 and pm 143 proteins transactivated the MCMV major immediate early 
enhancer and promoter (MIEPE) 3 fold above basal levels (Fig. 20). Since pml42 and 
pml43 are early proteins this could occur if  1) pml42 and pml43 are packaged in the 
virion and transactivate the MIEPE after virion attachment and penetration, or if 2) the 
pm l42 and pml43 proteins transactivate the MIEPE at early times in order to keep IE1 
and IE3 protein available for early gene expression. Since IE1 and IE3 protein are not
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expressed in the presence of phosphonoacetic acid (at early times), the former possibility 
is more likely.
HCMV IRS 1 and TRS 1 are packaged in the virion and they transactivate the 
HCMV MIEP following viral attachment and penetration. Interestingly m l42 and m l43 
have homology to IRS 1/TRS1, and are regulated similarly to IRS 1/TRS1. The proteins 
pm l42 and pml43 are also nuclear proteins. Therefore, pm!42 and pml43 could act as 
virion regulatory proteins in a manner similar to IRS 1/TRS 1. According to our 
immunofluorescence analysis, pm 142 and pm 143 are also found predominantly in the 
cytoplasm at late times, like ERS 1/TRS 1. This might be important in the packaging of 
these proteins in the virion. To date, no MCMV virion components have been identified 
with transactivating function. Our laboratory is currently investigating the ability of 
pm 142 and pm 143 to be packaged in the virion.
In order to do this, we will be purifying virion particles from glycerol gradients. 
These purified virions will be subjected to Western blot analysis using pm!42 and pml43 
antisera. If  pml42 and pm!43 do localize to the virion, we will continue our studies by 
determining if pm 142 and pml43 localize to the surface of the viral envelope or reside 
within the virion. In order to do this, protease digestion assays will be done using 
trypsin. Trypsin treatment of the virion will degrade proteins outside the viral envelope. 
Following trypsin treatment, Western blot analyses will be done using pm l42 and pm 143 
antisera. If pml42 and pml43 are located within the virion particle, this will suggest that 
they may be tegument proteins. If  pm 142 and pm 143 are tegument proteins, they likely 
transactivate the MCMV major immediate early enhancer and promoter (MIEPE) 
immediately following viral entry into the host cell.
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Alternatively, it is possible that there may be some low level expression o f IE 1 
and IE3 protein at early and late times. In a time course experiment, EE1 and IE3 are 
expressed most abundantly at 2 hours post infection. However, these proteins remain 
throughout the course of the viral infection at low levels. The IE1 and IE3 proteins 
however are not detectable under conditions in which only early genes are expressed.
This suggests that the IE I and IE3 protein is relatively stable. Therefore, it is not likely 
that pm 142 and pm 143 transactivate the MIEPE at early times.
In order to determine if  pm!42 and pml43 transactivate the MIEPE, we varied the 
amount of l42/l43pCDNA transfected with the MIEP-reporter construct (Fig. 20).
When 1 pg of 142/143pCDNA effector plasmid was cotransfected with Ipg of target 
plasmid MIEP-CAT (E:T ratio of 1:1), no transactivation above basal levels was 
observed. Transactivation was observed (3-4 fold above basal levels) when 2 pg or 3 pg 
o f 142/l43pCDNA effector plasmid was cotransfected with I pg of target plasmid MIEP- 
CAT (E:T ratio o f 2:1 or 3:1). The effector to target ratio o f 1:1 is what likely occurs 
during a natural infection, not 2:1 or 3:1 ratio, since there is one copy of the iel/ie3 gene 
locus per m!42/ml43 gene locus in an infected cell. Therefore, it is possible that these 
findings were not biologically relevant and do not occur during a normal infection. On 
the other hand, if pm 142 and pm 143 are packaged in the virion, it is likely that a target 
ratio of 1:1 would not be taking place during a natural infection. Depending on how 
much pml42/pml43 is packaged in the tegument, ratios of at least 2:1 or 3:1 could be 
reached, thus making these findings more indicative o f  what takes place during a natural 
infection.
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We also found that pml42 and pml43 have additive effects with IE1 and IE3 in 
the activation of the MIEP (Fig. 25). These results were not surprising because the other 
immediate early proteins (IE1 and IE3) have independent effects on the activation o f the 
MIEP and when these proteins are introduced collectively, their effect on the MIEP is 
additive (Fig. 3). The potential mechanism by which these proteins could transactivate 
the MIEP will be discussed later.
Failure of the 142pCDNA and 143pCDNA expression vectors to reproduce the 
results found with 142/143pCDNA. Proteins expressed from 142/143pCDNA (which 
expresses pm l42 and pml43) were able to transactivate the MIEP. However when the 
m l42 expression vector (142pCDNA) and the m l43 expression vector (143pCDNA) 
were cotransfected, they failed to reproduce the results found with 142/143pCDNA (Fig. 
21). We believe that the phenomenon of squelching may account for the discrepancies in 
our transfection experiments. There is precedence that squelching occurs when 
transcriptional transactivators are overexpressed in transfection assays. For example, 
when the acidic domain of the HSV-1 regulatory protein VP 16 (virion protein 16) was 
overexpressed in transfection assays, the transactivating ability of this protein was 
inhibited (Pfitzner et al., 1993). More specifically, the overexpressed VP 16 protein 
interacted with and sequestered a basal transcription factor that was required for 
transcription. Other overexpressed transcriptional transactivators interact with and 
squelch common transcriptional transactivators like SP1 (Pfitzner et al., 1993).
High levels o f pmI42 and pml43 protein were expressed from the plasmids 
142pCDNA and 143pCDNA, respectively when compared to proteins expressed from
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142/143pCDNA (Fig. 22). This was because the expression from 142pCDNA and 
143pCDNA was driven by the strong HCMV enhancer located directly upstream of the 
m l42 and m l43 genes. A low level o f  expression of pmI42 and pmI43 from the 
!42/143pCDNA expression vector, was likely driven by the m l42 and ml43 native 
promoter, which is relatively weak. It is likely that the high levels of pm 142 and pm 143 
expressed from 142pCDNA and 143pCDNA, respectively cause transcriptional 
interference by sequestering a transcription factor, coactivator or protein within the basal 
transcription factor complex which is present in limiting quantities. In the absence of this 
component, expression from the reporter plasmid is inhibited. We can determine if 
squelching is taking place with these constructs by transfecting cells with the 
142/143pCDNA and MIEP-CAT. If the levels of CAT activity decrease when 
142pCDNA or 143pCDNA is titrated in, this would suggest that squelching is taking 
place.
It is also possible that because of the high level of protein expression from 
142pCDNA and 143pCDNA, pml42 and pml43 do not localize to the correct cellular 
compartment. If  pml42 and pm 143 do not localize properly, they will not be able to 
function properly. It is also possible that an alternate transcript may be expressed from 
!42/143pCDNA that is absent in 142pCDNA and 143pCDNA, which may be important 
in transactivation. In addition to the m l42 and ml43 transcripts, an additional transcript 
is expressed from this region (designated ml42c). Sequences from m l42c are contained 
within !42/143pCDNA. If a proteins expressed from ml42c are involved in 
transactivation, 142pCDNA and 143pCDNA combined would not be able to reproduce 
the results found with 142/143pCDNA. Lastly, a negative feedback loop mechanism
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may be involved, such that if  the level o f pml42 and pml43 surpasses a certain 
threshold, the activity of these proteins will be shut off.
In the future, expression vectors containing m l42 or ml43 und. er the control o f its 
native promoter will be made. These constructs will be tested in transiient assays in a 
similar fashion as !42pCDNA and 143pCDNA. The constructs containing m l42 or 
m l43 under the control of its native promoter will allow the function oof pm l42 or pml43 
to be determined while maintaining protein levels that are biologically relevant.
Transactivation of the e l promoter by pml42 a n d  pml43
We determined if pm 142 and pm 143 were able to transactivate an early gene that 
is involved in viral DNA replication. We tested the ability of pml42 amd pml43 to 
transactivate the el promoter (M l 12-113). The el gene is homologous to the HCMV 
UL112-113, which is required for HCMV ori-lyt dependent DNA replication. We found 
that the pml42 and pml43 proteins were not able to transactivate the eel promoter alone 
(Fig. 26). However in the presence of IE1 and IE3, cooperative activity was observed 
(Fig. 27). In the presence of 1 pg o f 142/143pCDNA, transactivation tiby IEI/IE3 
increased from 30 fold to 50 fold above basal levels. When the am ount of 
142/143pCDNA was increased to 3 pg, transactivation by IE1/IE3 increased to at least 
100 fold above basal levels. This was the first demonstration that otherr MCMV viral 
proteins assist in IE1/IE3 mediated transactivation o f the el promoter 0(M112-112) or any 
other promoter.
HCMV IRSl/TRSl acts synergistically with HCMV IE1 and LE2 to transactivate 
the UL112-113 promoter. Once more in these studies, pm 142 and pm! 143 are similar to
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IRS 1/TRS 1. The m l42 and ml43 gene products and IE1/IE3, act cooperatively to 
activate the e l promoter (M l 12-113), which is involved in viral DNA replication. The 
pm 142 and pm 143 proteins may help to activate the expression o f the other replication 
fork proteins as well. Like in HCMV, MCMV regulatory proteins are probably more 
efficient at activating viral replication fork proteins when present collectively.
As stated previously, transactivation by IEI/IE3 was increased in the presence of 
proteins expressed from 142/l43pCDNA (Fig. 27). However, when the IE1 and IE3 
expression vector was cotransfected with 142pCDNA and 143pCDNA, cooperative 
activity did not occur (Fig. 28). This is likely due to squelching, since very high levels of 
pm l42 and pml43 were expressed from 142pCDNA and 143pCDNA under these 
conditions (Fig. 29). It is also possible that improper protein localization may occur due 
to the high protein levels expressed from 142pCDNA and 143pCDNA, or a negative 
feedback control mechanism is being used. In the future, these experiments will be 
repeated using constructs expressing the m l42 or m l43 protein under the control o f its 
native promoter. The m l42 and m l43 native promoters are not as strong as the HCMV 
MIEP, and therefore the squelching phenomenon will probably be prevented.
The cooperative results with IE1/IE3 and m l42/m l43 can be interpreted in 
different ways, since the effector plasmid (pIEl 11 which expresses IE1 and IE3) used in 
the experiment is under the control of the MIEP, and the IE3 protein represses expression 
from this promoter (Messerle, 1992). The pm l42 and pm l43 proteins have also been 
shown to regulate this promoter. Furthermore, the m l42 and m l43 expression vectors 
contain the HCMV MIEP that may be regulated by MCMV IE1/IE3 proteins and pml42 
and pml43 as well. Therefore, it is difficult to know for sure if  the cooperation occurs
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because pml42 and pm 143 are increasing the expression o f EE1 and IE3 by activating the 
MIEPE, or if the effect of the pml42 and pm!43 proteins is more directly related to the 
el promoter. In the future, these experiments will be repeated with the effector plasmids 
cloned under the control of a heterologous promoter like the S V40 promoter.
Potential Mechanism of pml42 and pml43 Gene Regulation
There are several potential mechanisms by which pm 142 and pm 143 could 
regulate the MIEPE (M l22-123) and the el (M l 12-1123) promoters. These proteins 
could 1) activate the expression of a cellular transcription factor, 2) bind directly to viral 
promoter or enhancer regions 3) interact with transcription factors or components of the 
basal transcription factor complex to facilitate transcription, or 4) bind to an inhibitor of a 
transcription factor.
The pm 142 and pm 143 proteins could activate the expression of a cellular factor 
that is important in the transactivation of viral promoters. The MCMV MIEPE and the 
Ml 12/113 promoter have very complex promoter/enhancer regions containing several 
cellular transcription factor binding sites. In HCMV, IE 1 and IE2 proteins can regulate 
the expression of cellular genes involved in cell growth or cell cycle control. HCMV IE 1 
and IE2 can transactivate the c-fos, c-myc and hsp70 promoters, thus allowing the 
conditions within the cell to become more favorable for a permissive viral infection 
(Hagemeier et al., 1999). A similar scenario could be taking place with the pml42 and 
pml43. The pm l42 and pm!43 proteins transactivate the promoter of a cellular factor 
like c-fos, which then binds to viral promoter/enhancer regions to activate viral gene
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expression. The pm 142 and pm 143 could also activate cellular factors by other 
mechanisms such as effects on phosphorylation state o f these proteins.
Proteins pml42 and pml43 could directly bind DNA promoter/enhancer regions 
to regulate cellular and viral genes. The HCMV immediate early protein IE2, directly 
binds to DNA to autoregulate its own expression. HCMV IE2 binds to a region in the 
promoter referred to as the crs (cis repression sequence) (Lang and Stamminger, 1993) 
and thereby interferes with the formation of the preinitiation complex (Wu et al., 1993). 
HCMV IE2 also binds to elements within the promoter of the HCMV early UL112-113 
gene. It is possible that pm 142 and pm 143 could bind to cellular and viral promoters 
directly, to activate viral gene expression.
It is also possible that pml42 and pml43 could interact with components of the 
basal transcription factor complex or other transcription factors to facilitate the 
transcription of the cellular and viral genes. The HCMV IE2 protein has been shown to 
interact with several cellular transcription factors. The HCMV IE2 protein can bind to 
cellular transcription factors E2F-1, SP-1, TEF-1 and CTF-1 (Fumari et al, 1993; Lukac 
et al., 1994). HCMV IE2 can also interact with the TATA binding protein, which is a 
component o f the basal transcription factor complex TFIID (Jupp et al., 1993). Therefore 
pml42 and pml43 could regulate cellular and viral promoters by protein/protein 
interactions with a transcription factor or component of the basal transcription factor 
complex.
I believe that pm 142 and pm 143 regulate viral promoters by protein/protein 
interactions with a transcription factor or component of the basal transcription factor 
complex. The interactions between these proteins could enhance the function o f TFIID,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
113
by making TFIID more efficient or promoting the establishment o f the preinitiation 
complex. Since squelching likely occurs when pml42 and pml43 are over expressed, 
this suggests that these proteins are able to complex with other factors that are important 
in the transactivation o f the MIEPE and the e l promoter. Also, pm l42 and pml43 were 
not able to transactivate the el promoter alone, but were able to cooperate with IE1 and 
IE3. This suggests that protein-protein interactions are taking place.
To elucidate between the possible mechanisms in which pm 142 and pm 143 may 
regulate gene expression, several experiments can be done. In order to determine if 
pml42/pml43 binds to a certain viral or cellular promoter, Dnasel footprinting can be 
done. In this case, an end labeled probe containing a viral or cellular promoter sequence 
is incubated with pm l42/pm l43 (generated by vitro transcription/translation) to allow the 
formation of protein-DNA complexes. The protein-DNA complex is then exposed to 
Dnasel and electrophoresed. If  pm 142/pm 143 binds to the DNA, the DNA will be 
protected in this region. The exact sequence of protein binding can also be determined 
with this method.
Electrophoretic mobility shift assays (EMSA) can also be used to determine if 
pm 142 and pm 143 bind to DNA directly. In this case, promoter sequences are labeled 
and used as probe. This probe is then incubated with in vitro translated pm 142 and 
pm 143. If the pm 142 and/or pm 143 protein interacts with the labeled probe, there will be 
a retardation in the migration o f the labeled probe upon electrophoresis compared to 
control samples. If there is evidence that pml42 and pml43 bind to the promoter 
sequence, more elaborate EMSA experiments can be done using 1) pm l42 or pml43 
antibody to confirm the presence of pm 142 or pm 143 in the protein-DNA complex by
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supershift 2) specific or nonspecific DNA competitors to determine the binding affinities 
o f the proteins or 3) mutated probes to determine to what sequences pm 142 and pm 143 
bind.
In order to determine if pml42 or pml43 interact with other viral or cellular 
transcriptional transactivators, MCMV infected cell lysates can be immunoprecipitated 
with pm 142 or pm 143 antibody, and co-precipitating proteins analyzed by Western blot 
using an antibody against the potential interacting protein. If  there is evidence of an 
interaction, more extensive studies can be done using glutathione -S-transferase (GST) 
fusion proteins. The m l42 and ml43 genes can be cloned in frame to GST to generate 
GST-ml42 and GST-ml43. GST-ml42 or GST-ml43 will then be immobilized on 
glutathione-agarose beads, and incubated with the labeled in vitro translated potentially 
interacting protein. The complexes will be run on an acrylamide gel, the gel dried, and 
exposed to xray film. If a band is detected, the labeled protein is likely complexing with 
pm l42 and pml43.
Conclusions
We have characterized the expression of the m l42 and m l43 genes and their 
products, which are essential for MCMV viral DNA replication. These findings were 
significant because m l42 and m l43 are novel immediate early genes and prior to these 
studies only three MCMV IE genes had been characterized. It was shown the pm 142 and 
pm 143 act cooperative with IE I and IE3 to transactivate an early promoter. This was the 
first demonstration of a MCMV protein assisting IE1/IE3 mediated transaction.
However, since m l42 and ml43 are essential for viral replication in fibroblasts, they
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likely have other functions that deem them necessary for viral replication. Therefore, 
more study needs to be done on the ml42-ml43 genes to elucidate other roles these 
proteins may play in viral infection.




Since pm l42 and pml43 are able to transactivate the same genes as MCMV IE1 
and IE3, pml42/pm!43 probably have an additional function that deems them essential 
for viral replication. In order to determine what this function is, fibroblast cell lines 
stably transfected with ml42 and m l43 genes will be made. Next mutant viruses, deleted 
o f m l42 and ml43 will be generated using these stably transfected cell lines to 
complement mutant virus growth. After the m l42-m l43 mutant viruses have been 
generated, they will be grown on normal fibroblast cells under condition in which IE, E 
or L genes are expressed. These cells will then be harvested and total RNA will be 
isolated. The RNA will be converted to cDNA. The cDNA will be labeled and used to 
probe microarrays containing MCMV genes. The results of the microarray analysis will 
determine where in the viral replication cycle m l42 and m l43 are necessary; IE, E or L 
times. These studies will give further insight as to the function o f these genes. Similar 
experiments will be done after growing the m l42-m l43 mutant viruses on different cell 
lines, like macrophages. This will allow us to determine if these genes are important in a 
specific cell type that is involved in the pathogenesis o f the virus.
In addition, promoter deletion analyses and gel shift analysis will be done to 
determine to which promoter sequences pm 142 and pml43 may bind. In parallel, single­
site and deletion mutations will be made within the m l42 and ml43 gene to determine 
which motifs are important in promoter activation. These mutants can also be tested with 
respect to DNA binding and protein-protein interactions.
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